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Abstract 
 
  Tetracycline stimulates both excision and transfer of a Bacteroides  
Conjugative transposon CTnDOT. It was shown previously that a gene, rteC, is 
necessary for tetracycline-stimulated transcriptional regulation of the xis2c operon, 
which contains the excision genes. The protein encoded by this gene, RteC, did not 
have primary amino acid sequence homology to any known proteins in the databases. 
Accordingly, I sought structural homologs of RteC. A three-dimensional structure 
prediction by Robetta suggested that RteC might have two domains, and the C-
terminal domain might have a winged helix motif. Based on the Robetta prediction, 
the human transcriptional factors E2F-4 and DP2 were identified as the most likely 
structural homologs of RteC. I made alanine substitutions within the putative DNA 
binding helix 3 region of RteC. Assays of xis2c::uidA activation by alanine mutants 
indicated that residues 174, 175, 178, 180, and 184 in helix 3 might contact the 
upstream region of PE. The same alanine RteC mutants were used to test the effect of 
mutations on binding, and all mutants lost binding to PE region. The upstream region 
of xis2c contained two inverted repeat half-sites. Mutational analysis of these half-
sites showed that both half-sites are important for activity. In vivo GUS assays were 
 III 
also done to test whether these half-sites are important for binding. Disrupted 
inverted repeat sequences resulted in loss of binding to PE region. Thus, I have 
identified the DNA binding portion of RteC and DNA site to which it binds. 
  The tetracycline regulated excision operon, containing xis2c, xis2d, and 
exc of the Bacteroides conjugative transposon CTnDOT has been shown to mediate 
not only the excision of CTnDOT and but also the regulation of transcription of a 
large operon containing genes required for transfer of the CTnDOT transfer 
intermediate. In this study, the importance of two excision proteins (Xis2c and 
Xis2d) was examined to determine their roles in regulating the transcription level of 
the transfer operon. In-frame deletions in xis2c and xis2d, and deletion of exc 
reduced the in vivo transcription induction of the operon by 58%, 97%, and 16% 
respectively. Xis2c and Xis2d were shown to bind to the 450-bp DNA fragment 
immediately upstream of the first gene in the transfer operon but Exc did not exhibit 
any gel shift activity. However, Exc appeared to bind cooperatively when added to 
Xis2d and caused a super shift of the fragment. I obtained a footprint of Xis2d 
covering a 50-bp region immediately upstream of the promoter of the transfer 
operon. Mutations within this region had varying effects on the transcriptional 
activity in vivo and resulted in a loss of Xis2d binding. The same mutations also 
 IV
affect a crude preparation of Xis2c in its ability to bind DNA. My results confirmed 
the importance of Xis2c, Xis2d, and Exc in the transcriptional regulation of the 
transfer genes. 
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Chapter 1 
INTRODUCTION 
 
1.1 Bacteroides spp. and their clinical significance 
  Bacteroides are gram-negative obligate anaerobes. They form a major 
part of the normal bacterial flora of humans. Bacteroides spp. are predominant 
members of the human colon microbiota (41, 55). In the gut, they utilize complex 
polysaccharides that are not digestible by the host (55). In general, Bacteroides spp. 
are advantageous, providing nutrients for the host and stimulating mucosa cell 
turnover. However, they are also opportunistic pathogens. Colonic Bacteroides 
species such as B. fragilis, B. thetaiotaomicron, and B. ovatus can cause various 
infections, including blood stream infections and abscesses in the abdominal cavity, 
brain, or lung (6, 31, 49, 55). In the past, these anaerobic infections could be easily 
treated by antibiotics. But infections caused by Bacteroides spp. have become more 
difficult to treat because of increasing antibiotic resistance (11, 56, 57, 60, 69). 
  Human colonic bacteria, including Bacteroides, transfer resistance genes 
among themselves. They may also transfer or obtain such genes from bacteria that 
are passing through the colon (56). Proof that resistance gene transfer actually 
 ２ 
occurs comes from the finding that DNA sequences of resistance genes from 
different species and genera of bacteria in the colon and in other sites are virtually 
identical (56). In particular, it was found that antibiotic resistance genes may be 
transferred between Gram-positive and Gram-negative bacteria (56).   
  Bacteroides in the human colon are resistant to β-lactam antibiotics (8, 
83) and all aminoglycosides (12, 55). This is because Bacteroides produce β-
lactamases (8, 46, 47, 62, 82, 84) and are unable to transport aminoglycosides (1). In 
years past, tetracycline was used to treat Bacteroides infections. However, 
tetracycline has become useless because nearly 100% (13) of all Bacteroides clinical 
isolates contain the tetracycline resistance gene, tetQ (42, 72, 73). A new 
tetracycline analog (tigecycline) seems to be effective but resistance has already 
begun to appear (N. Shoemaker, unpublished data). Bacteroides spp. also have 
become resistant to clindamycin, an antibiotic widely used to treat Bacteroides 
infections in the past (8, 83). The increase in resistance among Bacteroides spp. 
appears to be the result of acquisition of antibiotic resistance genes by horizontal 
gene transfer (11, 56, 57, 60, 69).  
  Hybridization analysis of community samples collected from three 
different time periods (pre-1970, 1970~1980, and 1996~1997) showed a dramatic 
 ３ 
increase of resistance to tetracycline and erythromycin over time (69). Therefore, 
spread of antibiotic genes is not limited to clinical samples. All the tetracycline 
resistant strains contained tetQ (69), a gene that encodes a ribosome protection type 
of tetracycline resistance (43). Before 1970, 28% of community samples carried 
tetQ (6). Carriage was increased to 83% by 1996~1997 (69). Similarly, the number 
of strains containing erythromycin resistance genes has increased between the pre-
1970 period and 1996 and 1997 (69). The majority of the erythromycin resistant 
strains carried either ermF or ermG (69). These two genes belong to the macrolide-
lincosamide-streptogramin B (MLS) family of resistance genes (52, 94). These 
genes are also responsible for resistance to clindamycin, and this may explain 
increased resistance to clindamycin among Bacteroides spp.  
  Among Bacteroides spp., antibiotic resistance genes are acquired by 
horizontal gene transfer. Many Bacteroides strains contain one or more plasmids (13, 
77, 90). Previous work showed that some antibiotic resistance genes were spread by 
horizontal transfer of these plasmids (29, 98). However, most of the antibiotic 
resistance transfer among Bacteroides spp. is now known to be mediated by 
conjugative transposons (CTns) (2, 18, 21, 33, 51, 61, 89). Most of the antibiotic 
resistance genes found in Bacteroides spp. are on mobile integrated elements such as 
 ４ 
conjugative transposons (CTns) and non-replicating Bacteroides units (NBUs) (11, 
57, 74, 97). CTns and NBUs are DNA segments that are normally integrated into the 
bacterial chromosome and can be excised and transferred from donor to recipient by 
conjugation (96).  
 
1.2 The Bacteroides conjugative transposon, CTnDOT 
  Conjugative transposons (CTns) are DNA segments that are normally 
integrated in bacterial chromosome but can be excised and transferred from donor to 
recipient by conjugation. CTns are similar to transposons and temperate 
bacteriophages because they integrate into DNA (62). They resemble plasmids since 
the excised intermediate forms a covalently closed circle, and this circular 
intermediate contains a transfer origin (oriT) sequence that allows it to be transferred 
by conjugation (17, 38). CTns carry antibiotic resistant genes. Genes encoding 
resistance to tetracycline, erythromycin, kanamycin, chloramphenicol, streptomycin, 
sulfamethoxazole, and trimethroprim have been found on CTns (21, 89). Like self-
transmissible plasmids, CTns have broad host ranges and are responsible for 
antibiotic resistance gene transfer among both gram-positive bacteria and gram-
negative anaerobes (4, 17, 23, 44, 73).  
 ５ 
  The size of conjugative transposons ranges from 18 kb to more than 500 
kb (64). CTns have genes required for excision, transfer, and conjugation. They also 
contain antibiotic resistance genes and other accessory genes. In Bacteroides species, 
smaller integrated elements such as NBU1, Tn5520, Tn4555 were found, and they 
have been called mobilizable elements (MTns). MTns are smaller than CTns, and 
they are caused by CTns to be excised and transferred from donor to recipient (59, 
63). Co-resident plasmids that are not able to transfer by themselves are also 
mobilized by CTns. Sequence analysis of NBU1, Tn5520, and Tn4555 showed that 
these MTns, like the CTns, are member of lambda family of integrases (70, 87, 88). 
Conjugative and mobilizable transposons play an important role in antibiotic 
resistance transfer, but they are also able to transfer other metabolic traits (64).  
  The most studied conjugative transposons are the gram-positive 
conjugative transposon, Tn916, and the Bacteroides conjugative transposon, 
CTnDOT. Tn916 was first found in Enterococcus faecalis and it is the smallest 
known conjugative transposon with a size of 18 kb (67). It carries a tetracycline 
resistance gene, tetM, a gene that encodes a ribosome protection protein. CTnDOT is 
a conjugative transposon that was first found in a Bacteroides strain in a patient with 
a serious Bacteroides infection (64, 69). CTnDOT type elements play an important 
 ６ 
role in transferring antibiotic resistance genes among Bacteroides species in the 
colon (62, 69, 97). The size of CTnDOT is 65 kb and it carries two resistance genes: 
a tetracycline resistance gene (tetQ), and an erythromycin resistance gene (ermF) 
(Figure 1.1). The tetQ gene encodes a cytoplasmic protein which protects the 
ribosome from tetracycline (20), while the ermF gene encodes a protein that 
modifies the 23S rRNA molecule, preventing erythromycin from binding to the 
ribosome (94). Both Tn916 and CTnDOT have similar series of steps in excision 
and transfer (64). When they are excised from the chromosome, a chromosomal 5-
bp coupling sequence near the excision site is incorporated in the circular form (64) 
(Fig. 1.3). This coupling sequence is later introduced into the target site when the 
CTn integrates into recipient’s chromosome (64). Tn916 and CTnDOT differ 
somewhat in the specificity of integration (64). Tn916 integrates into random sites in 
recipient’s chromosome, while integration of CTnDOT is site-selective into about at 
least 7 sites on the Bacteroides chromosome (9, 64). Site selectivity of CTnDOT 
might occur because CTnDOT contains a 10-bp consensus sequence at the right end 
of the CTn, which has sequence identity to a 10-bp sequence next to the integration 
site (15). Transfer of both Tn916 and CTnDOT is stimulated by tetracycline (63). 
The mechanism of this stimulation, however, is different. In the presence of 
 ７ 
tetracycline, CTnDOT transfer is regulated by three regulatory genes, rteA, rteB, and 
rteC (58, 76). Tn916 has no such regulatory genes.  
  Excision and transfer of CTnDOT occurs in three steps. At first, 
CTnDOT is excised from chromosome and forms a non-replicating double-stranded 
circle (Fig. 1.2). Once excised and circularized, this circle cannot replicate 
independently (64). Using primers that anneal to the ends of CTnDOT, a circular 
intermediate can be detected by PCR (15). If the CTn is in the chromosome, there 
are no PCR products because the 3’ ends of primers are towards the chromosome 
(15). A PCR product is made only when the CTn is excised and circularized (15). 
Southern blot analysis has also been used to confirm the joined ends of the circular 
form (68).  
  When CTnDOT is excised from the chromosome, it makes staggered 
cuts 5-bp away from its ends (Fig. 1.3). The circular intermediate thus ends up 
having 5-bp from the donor chromosome. The sequences from the chromosome are 
called coupling sequences, but they are not complementary to each other (64). When 
the circle is formed, a small region of heterology is made (15, 80) (Fig. 1.3). The 
region of heterology is resolved either by replication following integrating or by 
repair enzymes (15, 57) (Fig. 1.3).  
 ８ 
  The non-replicating circular intermediate is nicked at an internal oriT 
site and a single strand is transferred from donor to recipient by conjugation (60, 64, 
66). (Fig. 1.2) Mobilization genes (relaxase) are involved in the nicking of the DNA 
at the oriT site, and transfer genes form the mating bridge. The oriT site in CTnDOT 
has been narrowed down to less than 1kb.  
  Excision produces a double stranded DNA circle. (15, 64, 96) (Fig. 1.2). 
Integration requires super-coiled double stranded DNA. When the super-coiled DNA 
in attDOT was either cut or relaxed, integration was abolished (J. Laprise, 
unpublished data). Integration into the chromosome is done by a tyrosine 
recombinase type reaction (1, 15, 30, 50). Like phage lambda integration, integration 
of CTnDOT is non-homologous integration; sequence homology between the att site 
and the joined ends of the circular form is not required. Integration assays with a 
CTnDOT mini-element (a plasmid containing only the joined ends, the CTnDOT 
integrase, and the oriT) showed that disrupting the integrase abolished integration 
(15). This suggests that integrase is required for integration of CTnDOT (15). 
Integration in CTnDOT is not regulated by tetracycline (15).   
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1.3 Regulation of CTnDOT excision  
  
CTnDOT excision and transfer are both regulated (Fig. 1.4). Excision is 
induced by tetracycline (15, 16, 64, 75), and is regulated by three regulatory proteins 
encoded by rteA, rteB, and rteC (62, 76). The tetQ (62) gene is the first gene in the 
operon followed by two genes, rteA and rteB (9). TetQ protects the ribosome from 
tetracycline (20). It has been shown that transcription of tetQ, rteA, and rteB is 
constitutive, whereas the translation of these genes is increased by tetracycline (92). 
Tetracycline stimulation is mediated by a translational attenuation mechanism, 
which involves the leader region of the tetQ operon (91, 92) (Fig. 1.5). Between the 
tetQ promoter and the tetQ start codon, there is an mRNA leader region containing 
hairpin structures (91, 92). The main hairpin structure has a stem composed of two 
sequences, Hp1 and Hp8 (91, 92). The ribosome binding site for tetQ is in Hp8 (91, 
92). Within the leader region, there is 3-amino acid peptide that is required for 
regulation by tetracycline (91). Deletion analysis confirmed that between Hp1 and 
Hp8, another region, Hp2, is essential for tetracycline regulation of genes on the 
tetQ operon (91). Hp2 could form a hairpin structure with Hp1. In the presence of 
tetracycline, the Hp1-Hp2 structure is formed when ribosomes bound by tetracycline 
are stalled on the 3-amino acid peptide, making the tetQ ribosomal binding site 
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(RBS) available (91) (Fig. 1.5). This allows the ribosome to bind the RBS of tetQ 
and translate tetQ (91).   
  Previous studies identified both RteA and RteB as regulatory proteins 
based on amino acid similarity to other known two-component regulatory systems, 
with RteA being the histidine kinase-environmental sensor and RteB being the 
transcriptional activator (76). RteB activates the expression of a third gene, rteC, 
which controls the expression of genes essential for excision (40, 76). Previous work 
showed that RteC works as a positive regulator of excision genes since disrupted 
RteC abolished excision (16). When the rteC native promoter was replaced by the 
constitutive tetQ promoter, this construct was able to express both transcriptional 
and translational xis2c::uidA fusions in trans, suggesting that RteC itself, without 
RteA and RteB, is sufficient to express the excision gene operon (40).  
  In contrast to RteA and RteB, RteC did not have the primary amino acid 
sequence homology to known protein databases, and it did not have the part of 
obvious helix-turn-helix motif that many DNA binding proteins have. Also, the pI 
value of RteC is neutral, 6.9 (48). To check for possible structural motifs, I used the 
Helix-turn-helix prediction program NPS@ (http://npsa-
pbil.ibcp.fr/NPSA/npsa_hth.html), and PSIPRED protein prediction server 
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(http://www.psipred.net/psiform.html). However, no significant motif was found. 
Therefore, I decided to use a 3 dimensional structure prediction program, Robetta 
(35), in an attempt to find structural homologs of RteC. I was able to obtain a 
possible structure and function for RteC. I confirmed that RteC is a DNA binding 
protein that binds the upstream region of the excision operon to activate excision 
genes (48). In chapter 2, I describe my work on the characterization of RteC. 
Previously, four genes critical for excision of CTnDOT (intDOT, xis2c, xis2d, and 
exc) were identified (16, 75). Originally, xis2c and xis2d were designated as orf2c 
and orf2d, but these genes are now re-named because they are clearly involved in 
excision.  
  The expression of the integrase gene, intDOT, is constitutive since 
integration occurs both in the presence and absence of tetracycline (15, 75, 88). The 
intDOT gene is at one end of CTnDOT (Fig. 1.1), and belongs to the lambda 
integrase family of tyrosine recombinases (16). In phage lambda, the cleavage and 
ligation reactions occur in the 7-bp overlap region including the integration site, and 
this lambda Int requires homologous sequences in this region (7, 93). CTnDOT Int 
is not as strict as lambda Int in its requirement for homology. Recombination occurs 
with both complementary and non-complementary coupling sequences (26). The 
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other three genes (xis2c, xis2d, and exc) are located downstream of intDOT (40) (Fig. 
1.1). Excision of CTnDOT was abolished when these three genes were disrupted or 
deleted, while a deletion in the gene upstream of exc, orf3 did not affect excision 
(16).  
  The excision of the well-studied integration elements typically requires 
two proteins, an integrase (Int) and an excisionase (Xis). Phage lambda requires 
integrase as well as a small basic protein called Xis to excise the integrated form 
(36). The integrase triggers the strand-exchange reaction (3). The excisionase 
controls the direction of the reaction. Xis triggers the excision reaction by bending 
DNA and enhancing co-operative binding of the integrase to the att site (45, 85, 99). 
The Gram-positive CTn, Tn916, also requires both an integrase and a xis-like gene 
for excision (53, 54). Xis proteins of phage lambda and Tn916 are small basic 
proteins that belong to the recombination directionality factors (RDF) family (37).  
  In CTnDOT excision, Xis2c and Xis2d might have similar properties to 
that of phage lambda Xis and other site-specific recombination systems. Xis2c is a 
118 amino acid protein and its pI value is 10.7. Also it contains a helix-turn-helix 
(HTH) motif. Like Xis2c, Xis2d is a small basic protein (116 aa), with a pI value of  
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9.1 (80). Amino acid sequences of Xis2c and Xis2d do not have significant sequence 
homology to any proteins in the databases (80).  
  Exc is required for excision in vivo and it has topoisomerase function in 
vitro (16, 81). But excision still occurs in vivo at the wild-type level when the 
topoisomerase active site was disrupted (80). More recent studies have shown that 
Exc is stimulatory but not essential in vitro. This may be because Exc has a 
regulatory function in vitro, and Exc might stabilize the other excision components 
in vivo (80). The other explanation might be differences between in vivo and in vitro 
systems such as topology of DNA substrate (80). In the in vivo system, the 
substrates for excision, the left and right junction sequences of integrated CTnDOT 
(attL and attR), are located on the same DNA molecule (80). In the original in vitro 
system, these substrates were provided separately on plasmids, avoiding topological 
constraints (80). Exc may be necessary for excision from the substrate containing 
both attL and attR on the same molecule.  
  The Xer-mediated recombination system is an example of a 
recombination system that relies on topology of the substrates. Two recombinases, 
XerC and XerD, catalyze the recombination at the psi site, a site carried on pSC101 
(5, 10, 22). The Xer-mediated recombination at this site requires the same oriented 
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recombination sites and is dependent on an intra-molecular structure (5). PepA and a 
phosphorylated ArcA (ArcA-P) are the two accessory proteins that are required for a 
specific synapse topology formation that facilitates the intramolecular recombination 
(19, 78). These proteins are involved in the Xer-mediated recombination. PepA 
forms the complex that is needed for excision, and regulates the transcription of the 
carAB operon (14). ArcA-P is involved in the excision complex formation (19, 78). 
Exc might function like PepA and ArcA-P to form a specific synapse topology for 
intramolecular recombination in vivo (80). 
  When CTnDOT is excised from the chromosome, the CTnDOT 
integrase creates staggered cuts near each end of the CTn (Fig. 1.3). These staggered 
cuts include 5-bp segments from chromosome, and these become the part of joined 
ends upon circularizing the excised CTn (15, 80). The 5-bp segments are called 
coupling sequences. They form a heteroduplex because the two 5-bp sequences are 
not complementary to each other (15, 80). The heteroduplex is resolved either by 
replication following integration or by repair enzymes (15, 57). The fact that both 
coupling sequences are found in the recipient with the equal frequency suggests that 
heterology is resolved in favor of either one coupling sequence or the other with 
nearly equal frequency, rather than resolving unidirectionally (63). 
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  The two attachment sites at the ends of CTnDOT, attL and attR, have 
been localized using an in vitro competition assay (26). The minimal attL site is 
153-bp and this sequence is composed of CTnDOT sequence (138 bp) and bacterial 
chromosome sequence (15 bp) (26). The minimal attR site is 179-bp and contains 
164-bp of CTnDOT sequence and 15-bp of bacterial chromosome sequence (26). In 
both cases, the 15-bp bacterial chromosome sequences include the 5-bp coupling 
sequence. Mutational analysis and gel shift assays showed that a 6-bp region in attR 
is required for both excision and IntDOT binding (26). Using insertional 
mutagenesis, regions in attL site that are essential for excision were identified (26). 
The mutations might interfere with protein-protein or protein-DNA interactions. 
Similar mutations in the attR site did not affect excision, suggesting that excision of 
CTnDOT is aymmetrical regarding protein binding sites, and also involves multiple 
protein-DNA interactions (26). 
  Exposure to tetracycline is important since there is no excision or 
transfer in the absence of tetracycline (76, 92). The operon which contains the 
tetracycline resistance gene, tetQ, and two other regulatory genes, rteA, and rteB is 
critical for both excision and transfer of CTnDOT (9) (Fig. 1.5). It has been 
demonstrated that RteC acts as a positive regulator of the CTnDOT excision genes 
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in the xis2c operon (40). Thus RteC is important because it directly regulates the 
excision of the CTnDOT.  
 
1.4 Regulation of CTnDOT transfer  
  Like excision, transfer of CTnDOT is also regulated by tetracycline (Fig. 
1.5). The size of the CTnDOT transfer region is 18kb and it contains factors that 
mediate transfer; the transfer origin (oriT), mobilization genes (mob genes), and 
transfer genes (tra genes) (Fig. 1.1). The transfer region is located downstream of 
rteC, and this region is sufficient for CTnDOT transfer. That is, if this 18-kb transfer 
region is cloned into a non-mobilizable plasmid like pLYL05 (L.Y. Li, unpublished), 
the new plasmid, pLYL72 (38), becomes self-transmissible. Suprisingly, transfer of 
pLYL72 was not regulated by tetracycline. 
  It has now been shown that the excision operon regulates the transfer of 
CTnDOT. When pKSO1 (16), the plasmid containing the excision operon, was 
placed in trans with pLYL72 (38), transfer of pLYL72 plasmid became regulated by 
tetracycline. In the absence of pKSO1, transfer of pLYL72 was constitutive and 
tetracycline did not have any effect on transfer of this plasmid. Therefore, it appears 
that excision genes are involved in regulation of both excision and transfer of 
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CTnDOT. By coordinating regulation of excision and transfer, intact CTnDOT 
should be fully excised before transfer, insuring integration of the entire CTnDOT 
into recipient’s chromosome. 
  Sequence analysis of the 18-kb transfer region showed that the putative 
tra genes (designated traA to traQ) are transcribed in the same direction (11). To test 
whether the tra genes are part of a single operon, RT-PCR was performed (34). 
Primers were designed to amplify the junction between each two genes. All 
reactions made RT-PCR products, suggesting that these genes are transcribed as part 
of single mRNA (34). An insertional mutation between traA and traB caused a polar 
effect on downstream genes, including traG (11), and the transfer of CTnDOT was 
abolished (34). RT-PCR analysis of tra genes in the presence and absence of 
tetracycline showed that tra genes are regulated at the transcriptional level (34).  
  The central regulatory proteins, RteA, RteB, and RteC are involved in 
expression of the excision gene operon (40). To test the effects of RteC and the 
excision proteins on tra gene expression, the following system was constructed. The 
integrase gene and the joined ends of NBU1 or NBU2 were used to insert the central 
regulatory genes, tetQ, rteA, and rteB (ΩQAB) or tetQ, rteA, rteB, and rteC 
(ΩQABC) into the chromosome (97). The NBU integrase gene and end sequence 
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were used because the inserted DNA cannot be excised from the chromosome; the 
excision genes of NBU1 or NBU2 have been removed (71). Both the excision region 
(pKSO1) and the transfer region (pLYL72) were provided on plasmids, and RT-PCR 
was used to measure expression of tra operon (34). When both the central regulatory 
genes (ΩQABC) and the excision region (pKSO1) were present, expression of the 
tra operon was up-regulated by tetracycline (34). Without pKSO1, tra operon 
expression was low and constitutive. Previous work showed that pLYL72 was 
transferred constitutively without the central regulatory genes (38). Therefore, both 
the excision region and the central regulatory region are required for up-regulation 
of tra gene expression (34).  
  RteC regulates excision gene expression. To test whether RteC also 
controls the tra operon directly, the excision operon was placed under control of a 
heterologous promoter, PsusA (34). PsusA is a maltose-regulator promoter, and by 
placing the excision operon under control of this promoter, expression of excision 
genes were rendered independent of tetracycline (24). The new construct containing 
the excision region was called pGRW3. The expression level of the excision genes 
were measured by in vivo GUS assays, using a translational traA::uidA fusion 
pGW40.5 (34). The fusion was used as an indicator rather than measuring pLYL72 
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transfer frequency because of potential toxicity caused by overproduction of transfer 
proteins (34). GUS activity was up-regulated in the presence of pGRW3 (34). When 
excision of CTnERL, a CTn that is exactly the same as CTnDOT except that it does 
not have an ermF gene, was tested in the presence of pGRW3, CTnERL was excised, 
and excision was independent of tetracycline (34). The transfer genes were also 
expressed independent of tetracycline (34). Therefore, the excision region is 
sufficient to regulate tra operon expression (34).  
  It is interesting to note that Xis2c, Xis2d, and Exc are involved in both 
excision and transfer regulation of CTnDOT (Fig. 1.5). Both conjugative transfer of 
pLYL72 and the expression of transfer proteins were enhanced by tetracycline when 
the excision proteins (Xis2c, Xis2d, and Exc) were present (96). Xis2c and Xis2d 
did not have sequence homology to proteins in known protein databases, but they 
are small basic proteins. Xis2d contains a helix-turn-helix motif that many DNA 
binding proteins have. Therefore, these two proteins might be DNA binding proteins. 
Preliminary gel shift anlaysis showed that both Xis2c and Xis2d bind the upstream 
region of traA. Another excision protein, Exc did not bind this region in vitro. It has 
been shown that many topoisomerases alter DNA topology to modulate gene 
expression (27, 28). Exc might have the same function and modify local 
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supercoiling to enhance conjugative transfer of CTn and expression of transfer genes. 
Currently, I am working on identifying Xis2c and Xis2d binding sites within the 
upstream region of traA. Both in vivo GUS assays and in vitro footprint assays will 
be done to determine the binding sites of Xis2c and Xis2d (Chapter 3).  
  Previously, it was shown that pKS05, a plasmid containing a region of 3’ 
end of the exc gene, inhibits pLYL72 transfer (96) (Fig. 1.5). This 500-bp region 
also includes a small open reading frame (ORF) that was designated as rteR. To see 
if this ORF encodes protein, two stop codons were introduced into the putative ATG 
start codon and the second codon (34). The mutated rteR still inhibited the transfer, 
suggesting that the ORF does not encode RteR protein but may encode a regulatory 
RNA (34). To determine whether rteR was being transcribed and whether its 
expression was regulated by tetracycline, Northern blot analysis was done to 
compare RteR levels in BT4007 cells which carry CTnDOT, in the presence and 
absence of tetracycline (34). RteR was little less than 100nt in size and it was 
expressed constitutively (34). The 5’ end of rteR has now been shown to be located 
at the end of exc and the 3’ end has been located.  
  Some small RNAs bind to mRNA and attract protein Hfq, causing 
degradation of RNA (25, 32, 39, 79). To test if RteR makes tra mRNA unstable, 
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rifampin was added to the medium and RNA was prepared from cells. Rifampin 
binds the beta-subunit of RNA polymerase and inhibits DNA-dependent RNA 
polymerase, resulting in prevention of transcription of RNA. RT-PCR was used to 
detect the amount of traG message, and traG mRNA was not destabilized in the 
presence or RteR (34). Also, Hfq gene homolog has not been found in the B. 
thetaiotaomicron genome sequence (34). Therefore, RteR may not destabilize 
mRNA to down-regulate transfer at the transcriptional level. Instead, RteR might 
cause early termination by binding to mRNA, which was seen in another mobile 
element, pAD1 (86). Alternatively, RteR might destabilize tra genes other than traG.  
 
1.5 Concluding remarks 
  
In my dissertation, I focus on positive regulators of CTnDOT excision 
and transfer. Excision and transfer of CTnDOT are complex processes and are 
tightly regulated. At first, I characterized RteC, a positive regulator of the excision 
gene operon. This dissertation describes how I used the Robetta protein structure 
prediction server to test my hypothesis that RteC is a DNA binding protein that is 
involved in transcriptional activation. The excision genes play an important role in 
enhancement of both excision and transfer. As a second stage of my project, I 
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decided to follow up an observation by a previous student. I confirmed that two 
excision proteins, Xis2c and Xis2d, are DNA binding proteins that bind upstream 
region of transfer operon and regulate the expression of transfer genes. And Exc 
interacts cooperatively with Xis2d to enhance binding of Xis2d to the upstream 
region of traA in vitro. 
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Figure 1.1 Map of CTnDOT  
CTnDOT is 65kb, and it carries genes that confer resistance to erythromycin (ermF) 
and tetracycline (tetQ). At one end of CTn, integrase gene, int or intDOT, is located. 
The excision operon (xis2c-2d-exc) is 13kb and is required for both excision and 
regulation of transfer. The 7.1 kb central regulatory region contains tetQ, rteA, rteB, 
and rteC. The transfer region is required for transfer and is composed of an oriT site, 
mob and tra genes. The size of the transfer region is 18kb. Figure 1.1 is from Nadja 
Shoemaker. 
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Figure 1.2 Model for the steps in CTnDOT excision and transfer 
The integrated conjugative transposon (rectangle) in the chromosome of donor 
excises and forms a non-replicating circular intermediate. A single-stranded nick at 
the origin of transfer (oriT) in the circular intermediate occurs, and the nicked strand 
is transferred from the donor to recipient. In the recipient, the complementary strand 
is synthesized and the double-stranded intermediate integrates into the chromosome. 
The copy remaining in the donor is believed to reintegrate (probably in a different 
site) into the donor chromosome (97). 
 
 
 ３６
 
  
Figure 1.3 A schematic representation of excision and integration reactions of 
CTnDOT Int (IntDOT)  
5-bp staggered cuts adjacent to the 5-bp coupling sequences (indicated by bold 
arrows) are made by IntDOT. The circular intermediate is created with a region of 
heterology. During transfer, the recipient receives one of the two coupling sequences. 
In the recipient’s chromosome, a new target site is selected and the element 
integrates using the staggered cuts. There are conserved inverted repeat sequence in 
both attL and attR. These flank the coupling sequence, B and D’ on attL, and D and 
B’ on attR. Figure 1.3 is an adaptation of Dichiara et al (26).  
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Figure 1.4 Regulation of CTnDOT excision and transfer  
In the presence of tetracycline (Tc), the concentrations of TetQ, RteA, and RteB are 
increased by translational attenuation (TA). RteB activates RteC, and RteC activates 
the excision genes (xis2c, xis2d, and exc). Excision genes enhance both excision and 
transfer. The excision operon contains a small gene, rteR, that represses CTnDOT 
transfer.  
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Figure 1.5 Proposed model for translational attenuation by tetracycline 
In the absence of tetracycline (step I), mRNA is bound by ribosomes and the leader 
tripeptide are translated (dashed line). The ribosome binding site (rbs) of tetQ is in 
Hp8, and is not accessible because of the Hp1-Hp8 hairpin. In the presence of 
tetracycline (step II), ribosomes bound by tetracycline (indicated by an asterisk) stall 
on the leader peptide mRNA, altering mRNA structure. The ribosome binding site 
becomes available, and the tetQ gene is translated by ribosome that are not bound by 
tetracycline. The bound tetracycline is released from the ribosome because TetQ 
alters ribosome conformation (step III). The altered ribosome returns to step I (step 
IV). Since ribosome is not bound by tetracycline, the mRNA structures which embed 
the ribosome binding site can be reformed. Figure 1.5. is an adaptation of Wang et al 
(91).  
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Chapter 2 
  CHARACTERIZATION OF BACTEROIDES CTNDOT  
REGULATORY PROTEIN, RTEC 
Figures 2.1~2.6 and Table 2.1 have been published as part of the manuscript entitled 
“Characterization of the Bacteroides CTnDOT regulatory protein, RteC”, 
by Park and Salyers, J.Bacteriol., 2011. 
 
2.1 Introduction 
  Bacteroides spp. are one of the numerically predominant groups of 
bacteria in the human colon, where they account for about 30% of the microbiota 
(15). Bacteroides spp. can cause serious opportunistic infections if they escape from 
the colon due to abdominal surgery or other trauma. Infections caused by 
Bacteroides spp. are difficult to treat because of increasing antibiotic resistance. 
Antibiotic resistance genes are being spread among Bacteroides spp. by horizontal 
gene transfer (16, 18, 19). CTnDOT is a conjugative transposon that was found 
originally in a Bacteroides strain that was isolated from a patient with a serious 
Bacteroides infection (16, 22). Subsequent studies showed that conjugative 
transposons such as CTnDOT type elements play an important role in transferring 
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antibiotic resistance genes among Bacteroides spp. in the colon (22). The first step 
in CTnDOT transfer is excision from the chromosome to form a non-replicating 
circular intermediate (28). Previously, an operon containing genes important for 
excision was identified (xis2c, xis2d, and exc) (4). These genes are regulated at the 
transcriptional level (14). Excision is induced by tetracycline (3, 4, 20, 23). 
Regulation appeared to be mediated by three regulatory proteins encoded by rteA, 
rteB, and rteC (5). The tetQ gene is the first gene in the operon that contains rteA 
and rteB (9). Transcription of tetQ, rteA, and rteB is constitutive, whereas the 
translation of these genes is increased during exposure to tetracycline (27). Increased 
protein production is due to a translational attenuation mechanism (26, 27). Both 
RteA and RteB are clearly regulatory proteins based on amino acid similarity to 
known two-component regulatory systems, with RteA being a histidine kinase-
environmental sensor and RteB being a transcriptional activator (24). RteB activates 
the expression of rteC, which in turn controls the expression of genes essential for 
excision (14, 24). Previously, it was demonstrated that disruption of rteC abolished 
excision, suggesting that RteC acts as a positive regulator of excision genes (4). 
When rteC was placed under control of the tetQ promoter, so that rteA and rteB 
were no longer needed, and introduced in trans with both the transcriptional and 
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translational xis2c-uidA fusions, the construct stimulated the expression of the 
fusions (14). Therefore, RteC itself is sufficient to express the excision gene operon 
(14, 24). My hypothesis was that RteC is a DNA binding protein that binds upstream 
of the promoter of the xis2c operon, PE. Yet RteC did not have primary amino acid 
sequence homology to any known proteins in the databases. Accordingly, I decided 
to search for structural homologs of RteC to obtain insights into the possible 
structure and function of RteC.  
 
2.2 Materials and methods 
Strains and growth conditions 
  Bacterial strains and plasmids used in this study are listed in Table 2.1. 
The concentrations of antibiotics used were: ampicillin (Ap), 100 µg/ml; 
chloramphenicol (Cm), 15 µg/ml; kanamycin (Kn), 50 µg/ml; cefoxitin (Cef), 20 
µg/ml; erythromycin (Em), 10 µg/ml; gentamicin (Gen), 200 µg/ml; rifampicin (Rif), 
10 µg/ml. All the E.coli strains were grown in Lysogeny Broth (LB) or on LB agar 
at 37°C and the Bacteroides strains were grown in either Trypticase Yeast Extract 
Glucose (TYG) medium or Supplemented Brain Heart Infusion (BHIS) medium at 
37°C under anaerobic conditions. 
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Site-directed mutagenesis 
  Site-directed mutagenesis was done using a QuikChange Site-Directed 
Mutagenesis Kit (Stratagene) and iProof High-Fidelity DNA Polymerase (Bio-Rad). 
Oligonucleotide primers were synthesized by Integrated DNA Technologies 
(Coralville, IA). Plasmid pGFK24.1 (K. Moon, unpublished), a pCR2.1 vector 
(Invitrogen), containing the 300-bp region upstream of the xis2c operon, was used as 
a DNA template in site-directed mutagenesis of the upstream region of the excision 
operon promoter
 
(PE). Plasmid pGFK70.1 (K. Moon, unpublished), a pCR2.1 vector 
(Invitrogen), containing His6-tagged rteC, was used as a DNA template for site-
directed mutagenesis of RteCHis6 for in vivo GUS assays. The PCR amplicons 
containing different mutations were transformed into E.coli DH5αMCR competent 
cells (Bethesda Research Laboratories Inc., Gaithersburg, MD), and cells were 
grown in Lysogeny Broth (LB) agar medium containing ampicillin (100 µg/ml) or 
kanamycin (50 µg/ml) overnight. Plasmids were isolated, and then sequenced to 
confirm the mutation (UIUC Core DNA Sequencing Facility, Urbana, IL). For site-
directed mutagenesis of the upstream region of PE, the SphI-SmaI restriction 
fragments were isolated and ligated into the SphI-SmaI site of pMJF2 (6) to create 
an xis2c::uidA translational fusion, and then the SphI-PvuII fragments containing the 
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xis2c::uidA fusion were cloned into the SphI-NruI site of an E.coli-Bacteroides 
shuttle vector, pC-COW (9). For site-direted mutagenesis of RteCHis6, the NcoI-SmaI 
restriction fragments were isolated and ligated into the NcoI-SmaI site of pJPARK7 
to replace wild-type RteCHis6 with RteCHis6 mutants. pJPARK7 is a pAFD1 vector 
containing pPQ-rteCHis6. 
 
Triparental matings 
  The plasmids containing wild type RteC, mutant forms of RteC, or 
mutant forms of PE were mobilized into Bacteroides strain BT4001 via triparental 
matings. In each case, the two donors were E.coli DH5αMCR, which contained 
either mutations in the PE region or RteC mutants, and E.coli HB101, which 
contained the IncPα plasmid RP1 (21). RP1 cannot replicate in Bacteroides spp., but 
it does mobilize E.coli-Bacteroides vectors from E.coli donors to Bacteroides 
recipients (21). Matings were done on nitrocellulose filters. The plasmids were then 
mobilized into BT4001, a Bacteroides strain which contains pJPARK7, a pAFD1 
vector containing pPQ-rteC, or BT4001, which contains pGFK43.11, a pC-COW 
vector containing the PE xis2c:: uidA fusion.  
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GUS assay 
  The uidA reporter gene on pMJF2 encodes an E.coli β-glucuronidase 
(GUS). GUS assays were done by the procedure of Feldhaus et al (6). One unit was 
defined as 0.01A415U per min at 37°C. Protein concentrations were determined by 
the method of Lowry et al (12).  
 
Overexpression of RteC 
  
A promoterless rteC gene was amplified from BT4007 using PCR. High-
fidelity PCR amplification was done by PfuUltra High Fidelity DNA Polymerase 
(Stratagene). The 670-bp rteC PCR product was cloned into pCR-Blunt (Invitrogen). 
An NdeI-XhoI fragment was cloned into the NdeI-XhoI sites of pET28b (Novagen), 
creating His6-tagged rteC. Escherichia coli BL21 CodonPlus (DE3) RIL 
(Stratagene) was used as the host strain for wild-type RteC. Cells were grown 
overnight at 37°C in 10ml Luria Broth (LB) medium with chloramphenicol (50 
µg/ml) and kanamycin (30 µg/ml). The overnight cultures were used to inoculate 
500 ml of LB medium containing chloramphenicol (50 µg/ml) and kanamycin (30 
µg/ml). The culture was incubated with vigorous shaking at 37°C. Cells were grown 
until O.D.600 was 0.3~0.4, and isopropyl-D-thiogalactopyranoside (IPTG) was added 
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to a final concentration of 1mM. Cells were grown at 25°C for 3 to 4 hours with 
vigorous shaking. Cells were harvested by centrifugation at 7,000 rpm for 20 min at 
4°C. The supernatant fluid was discarded, and the cells were stored at –80°C until 
use. Overexpression of His6-tagged RteC protein was confirmed by Western blotting 
with Mouse anti-His Antibody (GE Healthcare) as a primary antibody and anti-
mouse IgG HRP (Promega) as a secondary antibody. The tagged RteC was tested in 
Bacteroides strain 4001 containing the PE xis2c::uidA fusion to ascertain that it 
activated the xis2c operon similarly to wild type RteC. 
 
Cell extract preparation and purification of RteC 
  The frozen cell pellet was resuspended in 10 ml lysis buffer (50 mM 
Tris; pH8.0, 1 M NaCl) to which one Complete Mini EDTA-free protease inhibitor 
tablet (Roche Applied Science) had been added. The cell suspension was frozen on 
dry ice and thawed in 37°C water bath 3 times. Then the cells were lysed by 
sonication (15 sec sonication and 2 min on ice, 6 times). Cell lysate was separated 
by centrifugation at 7,000 rpm for 20 min at 4°C. The supernatant was incubated 
with 1ml cobalt resin (Pierce) that had been equilibrated with lysis buffer at 4°C for 
1 hour, and passed over a gravity-flow column. The column was eluted with elution 
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buffer (50 mM Tris-HCl ; pH 8.0, 1 M NaCl, and 150 mM imidazole). The crude 
cell extract or the partially purified RteCHis6 was dialyzed overnight in a Slide-A-
Lyze cassette (Thermo Scientific) against dialysis buffer (50 mM Tris-HCl; pH 8.0, 
1 M NaCl, 1 mm DTT, 1 mM EDTA, 20% glycerol), and stored at -80°C until use. 
The partially purified RteCHis6 was analyzed by both SDS-PAGE and native gel and 
subjected to Western blot to determine the molecular weight.  
 
Gel shift assays 
  The 260-bp DNA fragments utilized in the gel shift assay experiments 
were prepared from plasmids containing wild-type or mutated PE region by 
restriction enzyme digest (SphI and SmaI) followed by gel extraction. DNA 
fragments were labeled with gamma-[32P] ATP using PCR, and purified. The DNA 
fragment (approximately 5ng) and either partially purified RteC or RteC cell extract 
were mixed in 10µl binding buffer and were incubated for 15 min at room 
temperature. The 5X binding buffer contained 250 mM Tris-HCl (pH 8.0), 5 mM 
EDTA, 250 mM NaCl, 50% glycerol, and 3.6 µg/ml herring sperm DNA. The 
binding mixture was loaded onto a 6% DNA Retardation Gel (Invitrogen), and 0.5X  
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Tris-borate-EDTA buffer (pH 8.0) was used as the running buffer. After 
electrophoresis, the gels were dried and subjected to autoradiography.
  
 
2.3 Results 
Structural homologs of RteC 
  The linear RteC amino acid sequence did not have significant homology 
to any proteins in the databases (14). Moreover, unlike many DNA binding proteins, 
which have a high pI, the predicted pI of RteC was 6.9. Accordingly, I decided to 
look for the structural homologs instead of relying on the linear amino acid sequence. 
To find the possible structural homologs of RteC, I used the protein structure 
prediction server Robetta (10). The Robetta server uses methods including PSI-
BLAST (1) and the Rosetta fragment-insertion to generate a hypothetical structure 
(5, 10). Models can be built by the de novo Rosetta prediction method (1, 5, 10). 
Based on the Robetta (10) prediction, I found that RteC might have two domains, 
including a C-terminal domain that contains a winged helix motif (8). A winged 
helix motif is a subfamily of the helix-turn-helix motif (8). This motif consists of 
three alpha-helices and two beta strands (8). Two anti-parallel beta strands make 
wings, and these wings flank the third helix (8). Typically, the third helix works as a 
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recognition helix and interacts with the major groove of DNA (8). Based on the 
Robetta structural prediction, when compared to structures in the database, human 
transcriptional factors E2F-4 (29) and DP2 (29) were the closest homologs with Z-
score of 6.46. E.coli LexA repressor (7), and E.coli arginine regulator ArgR (11) 
could also be structural homologs of RteC. The fact that all of these homologs are 
known DNA binding proteins supported the hypothesis that RteC is a DNA binding 
protein. E2F-4 forms a heterodimer with the other transcriptional factor, DP2 to 
efficiently bind DNA, and these two proteins share sequence homology in their 
DNA binding domains (29). I used ClustalW (25) to align the putative C-terminal 
domain of RteC, amino acid residues 111 to 217, with DNA binding domains of the 
human transcriptional factors, E2F-4 (29) and DP2 (29), and the secondary structure 
of the putative RteC DNA binding domain was obtained (Fig. 2.1). Since helix 3 
works as a recognition helix in many winged helix proteins, the putative helix 3 
region in RteC (residues 174 to 189) was subjected to mutation. 
 
Alanine substitutions in the putative RteC helix 3 
  I made 7 individual alanine substitutions within the putative helix 3 
region in RteC. Alanine substitutions were constructed at K174, D175, R178, F179, 
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Y180, K184, and E189 (Fig. 2.2A in bold). The RteC alanine mutants were then 
tested for the ability to activate the wild-type xis2c::uidA fusion. I found 3 amino 
acid
 
residues that were fully conserved in RteC (residues 174, 178, and 180), E2F-4 
(residues 118, 123, and 125) and DP2 (residues 55, 57, and 59). The single alanine 
substitution of these
 
amino acids resulted in decreased activity to the background 
level (Fig. 2.2B). Mutations at D175 and K184 rendered defective for transcription 
activation of xis2c::uidA (Fig.2.2B). Mutations at F179 showed 20% decreased 
activity, while an alanine substitution at E189 did not affect the activity compared to 
the wild-type (Fig. 2.2B). These results show that portions of helix 3 of RteC is 
important for RteC activity. 
 
Site-directed mutagenesis of upstream region of PE 
  I
 
also wanted to define the RteC DNA binding site upstream of PE. 
Preliminary analysis had suggested that the 20-bp between –51 and –70 relative to 
the xis2c transcriptional start site might be important for activity (14). To identify 
the important base pairs within this 20-bp region, 5 different 4-bp mutations were 
made within this region (Fig. 2.3A). The changes were complementary to conserve 
the melting temperature characteristics. The effects of mutations on activity were 
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measured by an in vivo GUS assay. The results of each set of 4-bp mutations within 
the 20-bp region upstream of PE on the xis2c::uidA are shown in Figure 2.5B. Cells 
containing both wild-type 20-bp and wild-type RteC exhibited a 100-fold increase in 
GUS activity compared to cells without RteC (Fig.2.3B). The 4-bp change between 
–67 and –70 did not affect the GUS activity, while the 4-bp mutations of the 
downstream 16-bp resulted in more than 2-fold decreased GUS activity (Fig. 2.3B). 
When the entire 20-bp region was changed, the activity was decreased 8-fold (14). 
The 20-bp region contained a 7-bp inverted repeat half-site. Another inverted repeat 
half-site was located immediately downstream of the 20-bp sequence, from –49 to –
43 relative to the xis2c transcriptional start site. The fact that mutations in the part of 
20-bp that contained one inverted repeat half-site resulted in 8-fold decreased 
activity (3), but did not decrease GUS activity to the background level may mean 
that both half-sites must be mutated to eliminate gene expression. 
  More site-directed mutagenesis was done to determine important base 
pairs adjacent to the 16-bp region from –51 to –66. To test our hypothesis that RteC 
may bind the two inverted repeat half-sites and that the -33 region may be important 
for activity because it is part of the PE promoter, 4 different sets of mutations were 
made within the upstream region of PE. One inverted repeat half-site mutation from 
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–43 to –49, the other inverted repeat half-site mutation from –53~-57, and the -33 
region were changed by site-directed mutagenesis (Fig.2.4A). The region from –35 
to –38 was called the -33 region, because of its sequence similarity with other 
Bacteroides promoter regions (2). In Bacteroides, there are conserved –7 and –33 
regions which are analogous to the –10 and –35 region in E.coli (2). The 20-bp 
region from –45 to –65 relative to the xis2c transcriptional start site was chosen 
since mutation of 4-bp from –67 to –70 did not affect the activity (Fig.2.4A). 
Changes in the two inverted repeat half-site mutations were transition mutations to 
destroy the inverted repeat sequence. The 4-bp mutation from –35 to –38, the -33 
region, and the mutations from –45 to –65 were to complementary sequences to 
conserve the melting temperature characteristics. When the one inverted repeat half-
site from –43 to –49 (TCACGTA) was mutated, the activity was decreased about 2-
fold compared to the wild-type control (Fig.2.4B). The other inverted repeat half site 
mutation from –53 to –57 (TACGT) showed about 12-fold decreased activity 
(Fig.2.4B). With the mutated –45 to –65 region, the activity was decreased almost to 
the background level (Fig.2.4B). The activity was decreased about 10-fold in the 
case of the -33 region mutation (Fig.2.4B). This result suggested that both inverted 
repeat half-sites are important for RteC binding.  
 ５２
The effect of PE region mutations on binding of RteC to DNA 
  My results supported the hypothesis that RteC is a DNA binding protein 
that binds the upstream region of PE and activates the expression of excision genes. 
To confirm that RteC binds DNA and recognizes the inverted repeat sequence within 
upstream region of PE, gel shift assays were done. Partially purified empty vector 
(no RteC) was used as a negative control (Figure 2.5B, lanes 2, 5, 8, and 11). In the 
gel shift assays, wild-type RteC binding to wild-type PE resulted in a super shift 
(Figure 2.5B, lane 3). However, when either inverted repeat half-site or the entire 
inverted repeat sequence was disrupted, the super shift no longer occurred (Figure 
2.5B, lanes 6, 9, and 12). This result showed that RteC can bind DNA in the PE 
region and confirm
 
that both inverted repeat half-sites are important for RteC 
binding.  
 
2.4 Discussion 
  RteC does not have primary amino acid sequence homology to any 
known proteins in the databases. To get past this, I used the protein structure 
prediction program, Robetta (10) to predict the structure of RteC in the hopes of 
finding other proteins with structural homology. I chose Robetta to predict the 
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structure of RteC because it can generate a model for an entire sequence without 
sequence homology to proteins of known structure (5, 10). Previously, I used the 
PSIPRED protein structure prediction server (13). The secondary structure 
prediction showed that RteC might contain many α-coils and β-sheets, but no clear 
motifs stood out. Thus the Robetta (10) program has been the most informative. 
Based on the Robetta prediction, I found 4 structural homologs of RteC and all were 
involved in transcriptional regulation. Those homologs were E2F-4 (29) and DP2 
(29), E.coli LexA repressor (7), and E.coli arginine regulator ArgR (11). These 
proteins all contain winged helix motifs in their DNA binding domains. Guided by 
this, I could see that RteC also appears to have such a motif. The pI of RteC was 
predicted to be 6.9, and the putative structural homologs of RteC, human 
transcriptional factor E2F-4 (29) and DP2 (29), and E.coli LexA (7) also exhibited 
neutral pI values. However, DNA binding domains of these proteins have higher pI 
values. In RteC, the predicted pI of the C-terminal domain is 9.1. This suggested that 
RteC amino acid residue 111~217 might be involved in DNA binding. All 4 
structural homologs of RteC work as dimers, and electrophoretic analysis under 
native condition confirmed that RteC forms a tetramer (Fig. 2.6B, lane 2). Since 
E2F-4 (29) and DP2 (29) were the closest structural homologs of RteC, based on the 
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Robetta prediction, these two transcription factors were chosen for comparison to 
RteC. The putative secondary structures of RteC DNA binding domains were 
obtained by aligning DNA binding domains of E2F-4 and DP2 with the C-terminal 
domain of RteC. Since the helix 3 works as a recognition helix in most winged helix 
proteins (8), the putative helix 3 of RteC was subjected to alanine substitutions. 
Western blot analysis confirmed that RteC mutants were stable and expressed at the 
same level as the wild –type.  
  Based on sequence alignment by ClustalW (8), three amino acid residues 
in the putative helix 3, K174, R178, and Y180, are fully conserved amongst RteC, 
E2F-4, and DP2. Both E2F-4 (29) and DP2 (29) use a conserved Arg-Arg-XXX-Tyr-
Asp motif to contact half of the palindromic sequence CGCGCG. (29). In E2F-4 and 
DP2, three amino acid residues in an RRXYD motif, two arginines and a tyrosine, 
directly contact the DNA (29), and both R178 and Y180 in the putative RteC helix 3 
were aligned with two of these three residues that are responsible for DNA contact. 
The alanine mutation at D175 resulted in about 10-fold decreased activity. In E2F-4 
and DP2, the aspartate in RRXYD motif makes charged hydrogen bonds to both 
arginines and appears to stabilize this arrangement (29). Both aspartates in the RteC 
putative helix3 might stabilize the other amino acids that contact DNA bases, and 
 ５５
this might explain the more than 10-fold decreased activity. Taken together, my 
results support the hypothesis that RteC is a winged helix type DNA binding protein 
and that the predicted DNA binding region, helix 3, is important for binding. 
  Preliminary evidence suggested that RteC might bind somewhere in the 
20-bp upstream of PE (-51 to –70). To narrow down the region that is important for 
activity, we made 5 sets of 4-bp mutations within this 20-bp region, and found the 
mutation of the first 4-bp (-67 to –70) did not have any effect (Fig. 2.3B). Since 
changing the entire 20-bp resulted in an 8-fold decrease in activity but did not 
decrease activity to the background level, we hypothesized that there might be 
another region important for activity. A closer look at upstream region of PE revealed 
an inverted repeat sequence, one half of which overlapped the 20-bp (-51 to –70). I 
made 4 different sets of mutations in the upstream region of PE (Fig. 2.4A). The 
activity was decreased when each inverted repeat half-site was mutated, and it 
decreased to the background level when inverted repeats were disrupted. Mutation 
of the -33 region resulted in 10-fold decreased activity, as expected if this region is 
part of the promoter (Fig. 2.4B). These results suggest that RteC may recognize and 
bind two inverted repeat half-sites, and that the -33 region is also important for full 
activity. In vitro binding of RteC to this region, as indicated by the ability to shift the 
 ５６
DNA, confirmed this result and added further support to the hypothesis that RteC is 
a DNA binding protein. The partially purified RteC contained non-specific binding 
proteins that were observed in gel shift assays. Therefore, I decided to do 
mutagenesis analysis instead of in vitro footprint assays. 
  In summary, I have confirmed that RteC is a DNA binding protein and 
we identified important amino acid residues that might be involved in DNA binding. 
A possible DNA target sequence on the DNA was also localized.  
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Figures and Tables 
 
 
Figure 2.1 The predicted RteC DNA binding domain  
The putative RteC C-terminal domain, residues 111 to 217, was deduced based on 
Robetta prediction results. Based on the Robetta prediction, the putative C-terminal 
domain might contain a winged helix motif because the human transcriptional 
factors, E2F-4 and DP2, the closest structural homologs, have winged helix motifs 
in this region. Amino acid sequences from 111 to 217 were aligned with the DNA 
binding domains of these structural homologs of RteC, and the putative secondary 
structure of RteC DNA binding domain was obtained. Three alpha helices are 
represented as H1, H2, and H3 in boxes. Beta-strands are shown as arrows labeled 
s1, s2, and s3.  
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Figure 2.2 Alanine substitutions within the putative RteC helix 3  
(A) The amino acid sequence of the predicted helix 3 that was subject to 
alanine substitutions. Based on sequence alignment with the structural  
homologs of RteC, fully-conserved, strongly-conserved, and non-conserved  
amino acid residues (in bold) in the predicted helix 3 were chosen. Amino acid  
residues that were changed to alanine are in bold. (B) The RteC
 
alanine  
substitution mutants were placed under control of the heterologous tetQ  
promoter and cloned into the E.coli-Bacteroides shuttle vector, pAFD1. The  
xis2c::uidA fusion was provided on a compatible E.coli-Bacteroides shuttle  
vector, pC-COW. In panel B, the values obtained with wild-type RteC were set  
to 100% and the activity of the each RteC mutant is represented as a  
percentage of the wild-type PE value. Without RteC, the GUS activity was less  
than 1 U/mg protein. The experiments were done in triplicate, and the mean  
values are shown above. Standard deviations are shown as error bars. 
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Figure 2.3 Site-directed mutagenesis of upstream region of PE   
(A)
 
In the region upstream of PE, 5 sets of 4-bp mutations were created in this region 
by site-directed mutagenesis. (B) In vivo GUS assay results for the mutated 
constructs are shown. In each case, wild-type PE or the PE mutations were fused to 
the E.coli uidA gene creating a translational fusion, and then cloned into the E.coli-
Bacteroides shuttle vector. His6-tagged RteC, under control of the heterologous tetQ 
promoter, was cloned into the other E.coli-Bacteroides shuttle vector, and then the 
two plasmids were mobilized into Bacteroides strain BT4001. In each panel, the 
values obtained with wild-type PE were set to 100% and the activity of the each PE 
mutant is represented as a percentage of the wild-type PE value. Without RteC, the 
GUS activity was less than 1U/mg protein. The experiments were done in triplicate, 
and the mean values are shown above. Standard deviations are shown as error bars. 
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Figure 2.4 Site-directed mutagenesis of the upstream region of PE   
(A) The region between –35 and –65 relative to the xis2c transcriptional start site, 
which contained the inverted half-sites and the –33 promoter region was subject to 
change. The inverted half-sites are indicted by solid line boxes. The dashed line box 
shows the 20-bp region initially targeted. –33 promoter region is underlined. 4 
different mutated PE regions were created by site-directed mutagenesis. Changes in –
46 to –65 and –35 to –38 were to complementary sequences. The other two PE 
mutations, from –43 to –49 and from –53 to –57, were transition mutations to 
eliminate the inverted repeat sequence. (B) In vivo GUS assay results are shown. In 
each case, wild-type PE or the PE mutations were fused to the E.coli uidA gene 
creating translational fusions, and then cloned into the E.coli-Bacteroides shuttle 
vector. His6-tagged RteC under control of the heterologous tetQ promoter was 
cloned into the other E.coli-Bacteroides shuttle vector, and then the two plasmids 
were mobilized into Bacteroides strain BT4001. In each panel, the values obtained 
with wild-type PE were set to 100% and the activity of the each PE mutant is 
represented as a percentage of the wild-type PE value. Without RteC, the GUS 
activity was less than 1 U/mg protein. The experiments were done in triplicate, and 
the mean values are shown. Standard deviations are shown as error bars. 
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Figure 2.5 Effects of PE mutation on RteC binding  
(A) Sequence of 3 different regions of PE are shown in boxes. The inverted half-sites 
are indicated by solid line boxes. The dashed line box shows the 20-bp region 
initially targeted. Sequences from –43 to –49 and from –53 to –57 relative to the 
xis2c transcriptional start site were changed to disrupt each inverted repeat half-site. 
The mutations were transition mutations. Sequences from –46 to –65 were changed 
to the complementary sequence to disrupt the inverted repeat sequence. (B) Gel shift 
analysis was done to test binding of RteC to wild-type and mutated upstream region 
of PE. Reaction conditions were as described in the Materials and Methods section. 
Lanes 1, 4, 7, and 10, labeled DNA without any protein; lanes 2, 5, 8, and 11, 
binding mix containing 5 µg of partially purified empty vector (pET28); lanes 3, 6, 9, 
and 12, binding mix containing 10 µg of partially purified RteC. The super shifted 
protein-DNA complex is indicated by the arrow. The other shifted band comes from 
an unknown component of the partially purified RteC preparation. The gel is a 
representative of three independent experiments. 
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Figure 2.6 Electrophoretic analysis of RteC  
(A) Electrophoresis under denaturing conditions. Lane 1, partially purified RteC on 
SDS gel; lane 2, Western blot analysis of RteC with anti-His antibody. RteC 
monomer (26 kDa) is indicated by the filled arrow. (B) Electrophoresis under native 
condition. Lane 1, partially purifed RteC on native gel; lane 2, Western blot of RteC 
with anti-His antibody. Location of RteC monomer (26 kDa) is indicated by the 
filled arrow. Hollow arrow indicates RteC tetramer (104 kDa). 
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Table 2.1 Bacterial Strains and Plasmids 
 
Strain or plasmid   Relavant Phenotype    Description and Reference 
E.coli 
DH5αMCR         RecA                Gibco BRL 
HB101(RP1)        RecAStrr                    HB101 containing IncPα plasmid RP1 (88) 
BL21-Codon Plus    Camr                         Cells enable high-level expression of  
(DE3)RIL                               heterologous proteins in E.coli (Stratagene) 
 
B. thetaiotaomicron 5482A 
BT4001             Rifr                           Spontaneous rifampin-resistant mutant 
BT4007             RifrTcrEmr            B. thetaiotaomicron 4001 that contains  
                                        wild-type CTnDOT 
 
Plasmids 
pMJF2              Apr(Emr)             A cloning vector to create a uidA fusion, also  
                                        an E.coli-Bacteroides shuttle vector 
pAFD1             Apr(Emr)              An E.coli-Bacteroides shuttle vector containing  
                                        ermF  
 pC-COW          AprTcrCmr(Cmr)          An E.coli-Bacteroides shuttle vector with IS4351 
-cat and Bacteroides plasmid pB8-51 that is  
compatible with pAFD1 and pMJF2-based  
vectors (40) 
 pCR-Blunt             Knr                        A 3.5-kb cloning vector for PCr product 
(Invitrogen) 
 pET28b               Knr                         A plamid for the overexpression of His6-tagged 
                                          proteins in E.coli (Novagen) 
 pGFK24.1             Apr                0.3-kb PCR product containing upstream region  
of the xis2c operon cloned into pCR2.1 
(K. Moon, unpublished) 
 pGFK43.11            Apr(Cmr)           A plasmid containing uidA fused to 300 bp  
upstream region of xis2c start codon cloned 
into pCR2.1 (K. Moon, unpublished) 
      pGFK70.1             Apr                         1.2-kb PCR product containing RteCHis6 cloned 
into PCR2.1 (K. Moon, unpublished) 
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Table 2.1 (continued) 
pGFK76.5             Apr(Cefr)            A plasmid containing an in-frame fusion of  
                                         His6-tagged rteC to the tetQ promoter 
                                         (K. Moon, unpublished) 
pJPARK5             AprTcrCmr(Cmr)       uidA fused 0.3-kb PCR product containing 
                                         4-bp mutated sequence between –67 and  
-70 upstream region of the xis2c transcriptional 
start site cloned into the NruI-SphI site of  
pC-COW (this study) 
pJPARK7             Apr(Emr)             1.4-kb SphI-SstI fragment from pGFK76.5  
                                         containing wild-type pPQ-rteC;His6-tagged 
                                         cloned into SphI-SstI site of pAFD1 (this study) 
pJPARK18            AprTcrCmr(Cmr)       uidA fused 0.3-kb PCR product containing 
                                         4-bp mutated sequence between –63 and  
-66 upstream region of the xis2c transcriptional 
start site cloned into the NruI-SphI site of  
pC-COW (this study) 
pJPARK19            AprTcrCmr(Cmr)       uidA fused 0.3-kb PCR product containing 
                                         4-bp mutated sequence between –59 and  
-62 upstream region of the xis2c transcriptional 
start site cloned into the NruI-SphI site of  
pC-COW (this study) 
pJPARK20            AprTcrCmr(Cmr)       uidA fused 0.3-kb PCR product containing 
                                         4-bp mutated sequence between –55 and  
-58 upstream region of the xis2c transcriptional 
start site cloned into the NruI-SphI site of  
pC-COW (this study) 
pJPARK21            AprTcrCmr(Cmr)       uidA fused 0.3-kb PCR product containing 
                                         4-bp mutated sequence between –51 and  
-54 upstream region of the xis2c transcriptional 
start site cloned into the NruI-SphI site of  
pC-COW (this study) 
pJPARK22            Apr                  0.3-kb PCR product containing 20-bp mutated 
                                          sequence between –46 and –65 upstream region 
                                          of the xis2c transcriptional start site cloned into 
                                          pCR2.1 (this study)                                     
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Table 2.1 (continued) 
pJPARK26             Knr                 760-bp PCR product containing wild-type 
                                          rteC cloned into pCR-Blunt (this study)   
pJPARK28             Apr                 0.3-kb PCR product containing 7-bp mutated 
                                          sequence between –43 and –49 upstream region 
                                          of the xis2c transcriptional start site cloned into 
                                          pCR2.1 (this study) 
pJPARK32             Knr                 760-bp NdeI-XhoI fragment from pJPARK26 
                                          cloned into NdeI-XhoI site of pET28b 
                                          creating His6-tagged rteC  (this study)   
pJPARK37            AprTcrCmr(Cmr)        uidA fused 0.3-kb PCR product containing  
                                          7-bp mutated sequence between –43 and –49 
                                          upstream of the xis2c transcriptional start site 
                                          cloned into the NruI-SphI site of pC-COW  
                                          (this study) 
pJPARK38            AprTcrCmr(Cmr)        uidA fused 0.3-kb PCR product containing  
                                          20-bp mutated sequence between –46 and –65 
                                          upstream of the xis2c transcriptional start site 
                                          cloned into the NruI-SphI site of pC-COW  
                                          (this study) 
pJPARK39            AprTcrCmr(Cmr)        uidA fused 0.3-kb PCR product containing  
                                          4-bp mutated sequence between –35 and –38 
                                          upstream of the xis2c transcriptional start site 
                                          cloned into the NruI-SphI site of pC-COW  
                                          (this study) 
pJPARK49            Apr(Emr)              1.2-kb PCR product containing RteCHis6 
                                          mutant (K174A) cloned into NcoI-SmaI site 
                                          of pC-COW (this study) 
pJPARK50            Apr(Emr)              1.2-kb PCR product containing RteCHis6 
                                          mutant (R178A) cloned into NcoI-SmaI site 
                                          of pC-COW (this study) 
pJPARK51            Apr(Emr)              1.2-kb PCR product containing RteCHis6 
                                          mutant (Y180A) cloned into NcoI-SmaI site 
                                          of pC-COW (this study) 
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Table 2.1 (continued) 
pJPARK63            Apr(Emr)              1.2-kb PCR product containing RteCHis6 
                                          mutant (D175A) cloned into NcoI-SmaI site 
                                          of pC-COW (this study) 
pJPARK64            Apr(Emr)              1.2-kb PCR product containing RteCHis6 
                                          mutant (E189A) cloned into NcoI-SmaI site 
                                          of pC-COW (this study) 
pJPARK65            Apr(Emr)              1.2-kb PCR product containing RteCHis6 
                                          mutant (K184A) cloned into NcoI-SmaI site 
                                           of pC-COW (this study) 
pJPARK66            Apr(Emr)              1.2-kb PCR product containing RteCHis6 
                                          mutant (F179A) cloned into NcoI-SmaI site 
                                           of pC-COW (this study) 
 pJPARK76            Apr                  0.3-kb PCR product containing 5-bp mutated 
sequence between –53 and –57 upstream of the 
xis2c transcriptional start site cloned into  
pCR2.1 (this study) 
pJPARK78            AprTcrCmr(Cmr)        uidA fused 0.3-kb PCR product containing  
                                          5-bp mutated sequence between –53 and –57 
                                          upstream of the xis2c transcriptional start site 
                                          cloned into the NruI-SphI site of pC-COW  
                                          (this study) 
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Chapter 3 
   EXCISION PROTEINS ARE POSITIVE REGULATORS  
OF BACTEROIDES CTNDOT TRANSFER 
 
3.1 Introduction 
  
In Bacteroides species, conjugative transposons (CTns) play an 
important role in spreading antibiotic genes (8, 9). CTnDOT is a 65-kb CTn 
containing a tetracycline resistance gene, tetQ, and an erythromycin resistance gene, 
ermF (1, 10, 11). A distinctive feature of the CTnDOT family of CTns is that both 
excision and transfer are stimulated by exposure of donor cells to tetracycline (17, 
18). In the presence of tetracycline transcriptional attenuation regulates production 
of proteins encoded a three-gene operon, which include the resistance protein TetQ 
and a two-component regulatory system, RteA and RteB (16, 17). Both RteA and 
RteB were identified as regulatory proteins based on amino acid similarity to other 
known two-component regulatory systems, with RteA being the histidine kinase-
environmental sensor and RteB being the transcriptional activator (12, 13). RteA and 
RteB activate the expression of a third regulatory gene, rteC, which controls the 
expression of an operon containing genes involved in excision (6, 13). In the case of 
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CTnDOT excision, 2 genes (xis2c and xis2d) are required for excision, and a third 
gene (exc) is stimulatory (2, 14). This effect has been shown both in vivo and in 
vitro. These three genes, along with the CTnDOT integrase (IntDOT), coordinate the 
excision of CTnDOT from its site in the host chromosome (2).  
  A recent surprising finding was that the CTnDOT excision proteins were 
also necessary for transfer gene regulation (5, 18). The expression of the transfer 
gene operon by tetracycline required not only the presence of the regulatory genes 
(rteA, rteB, and rteC) but also the excision genes (xis2c, xis2d, and exc) (5). When 
the excision genes were placed under control of a heterologous promoter, expression 
of the transfer genes occurred in the absence of rteA, rteB, and rteC (5). Although 
the excision genes were clearly required for transfer gene expression and had been 
shown to be required individually in in vitro excision assays, the role of Xis2c and 
Xis2d on transfer gene regulation had not been established. There was some 
evidence that deletion of exc abolished production of the transfer proteins, as 
indicated by the Western blot analysis (18). It was not clear whether Exc was 
required to stimulate tra gene expression or was stimulatory as in the case of 
excision. Gel shift assays using a 450-bp, sequence that contained 80-bp of the 
region upstream of the first gene of the transfer operon (traA), showed that several 
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overlapping DNA fragments within this region were bound by Xis2c and Xis2d, but 
no shift (or binding) was detected with Exc (J. Lee, unpublished). We showed the 
footprint of the Xis2d binding to a 50-bp region immediately upstream and adjacent 
to the promoter site. We also determined the effects of mutations within this region 
on the in vivo transcription and the in vitro gel shift assays. Our results support the 
hypothesis that both Xis2c and Xis2d are DNA binding proteins, that Xis2d is 
required for transfer gene regulation and that Xis2c makes a contribution but has a 
less dramatic effect. Exc appears to bind cooperatively with Xis2d. 
 
3.2 Materials and methods 
Strains and growth conditions 
  Bacterial strains and plasmids used in this study are listed in Table 3.1. 
The concentrations of the antibiotics used were: ampicillin , 100 µg/ml; 
chloramphenicol (Cm), 15 µg/ml; erythromycin (Em), 10 µg/ml; gentamicin (Gen), 
200 µg/ml; rifampicin (Rif), 10 µg/ml, tetracycline , 1 µg/ml. All the Escherichia 
coli strains were grown in Lysogeny Broth (LB) or on LB agar at 37°C and the 
Bacteroides strains were grown in either Trypticase Yeast Extract Glucose (TYG)  
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medium or Supplemented Brain Heart Infusion (BHIS) medium at 37°C under 
anaerobic conditions.  
 
Transfer of shuttle vectors 
  Vectors were transferred from E.coli donors to Bacteroides recipients by 
triparental matings using nitrocellulose filters on BHIS agar plates incubated 
aerobically as previously described (17). The Bacteroides thetaiotaomicron 
recipients contained either the entire CTn, CTnERL which is very closely related to 
CTnDOT or a strain, BT4001ΩQABC that contained tetQ-rteA-rteB and rteC 
integrated in the chromosome containing the traA::uidA reporter vector, pGW40.5 
(5) depending on the experiment being performed. 
 
Construction of deletion mutants 
  Deletions in xis2c, xis2d, and exc are shown in Fig. 3.1. 7.6-kb SphI-SstI 
fragment of pKSO1 (3) containing the excision gene operon was cloned into the 
SphI-SstI site of pAFD1 to create pJPARK82. This plasmid was used as a wild-type 
to compare effects of deletion mutations on activity. 2.1-kb SphI-SstI fragment of 
pGW41(3) containing xis2c and xis2d, but no exc, was cloned into the SphI-SstI site 
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of pAFD1 (pJPARK83). This plasmid was used as an exc deletion mutant. For in-
frame deletion of xis2c, a 3.7-kb PstI-SstI fragment from pGW53 (G. Whittle, 
unpublished) was cloned into the PstI-SstI site of pUC19, creating pGRW52. 
pGW53 is a pGERM-T vector containing PE-xis2c-xis2d-exc. Then a 650-bp PstI-
HincII fragment from pGRW52 was taken out, and 316-bp PstI-HincII PCR product 
containing PE-part of xis2c (31 out of 119 a.a.) was cloned into the PstI-HincII site 
of pGRW52 to make pGRW53∆2c’. To make an in-frame deletion of xis2d, the 1.1-
kb BstEII-PstI fragment from pGW53 was removed, and a 665-bp BstEII-PstI 
fragment containing PE-xis2c PCR product was cloned into the BstEII-PstI site of 
pGW53, creating pGRW53∆2d’. The PstI-SstI fragments containing each in-frame 
deletion were cloned into the E.coli-Bacteroides shuttle vector, pAFD1, to create 
pGRW53∆2c (in-frame deletion of 264 nucleotides from 5’ end) and pGRW53∆2d 
(in-frame deletion of the entire xis2d). Deletion mutations were confirmed by 
sequence analysis (UIUC DNA Core facility, Urbana, IL). 
 
Site-directed mutagenesis 
  To test the effects of various mutations in the region identified by the 
footprint analysis of Xis2d binding, several 5~7 bp site-directed mutations were 
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created in the upstream region of TraA. The effects of these mutations were tested in 
vivo by GUS fusion analysis and in vitro by gel shift analysis. Site-directed 
mutagenesis was done using a QuikChange Site-Directed Mutagenesis Kit 
(Stratagene) and PfuUltra DNA Polymerase (Stratagene). Oligonucleotide primers 
were synthesized by Integrated DNA Technologies (Coralville, IA). pJPARK85. A 
pCR-Blunt vector (Invitrogen), containing the 450-bp region upstream of the TraA (-
138 ~ +352), was used as DNA template in site-directed mutagenesis of the 
upstream region of the transfer operon promoter
 
(PtraA). The PCR amplicons 
containing different mutations were transformed into E.coli DH5αMCR competent 
cells (Bethesda Research Laboratories Inc., Gaithersburg, MD), and cells were 
grown in Lysogeny Broth (LB) agar medium containing kanamycin (50 µg/ml) 
overnight. Plasmids were isolated, and then sequenced to confirm the mutation 
(ACGT Inc. Wheeling, IL ). Once mutations were confirmed, the SphI-SmaI 
restriction fragments were isolated and ligated into the SphI-SmaI site of and E.coli-
Bacteorides shuttle vector, pMJF2, to create an traA::uidA translational fusion. 
Mutated forms of the traA upstream region were affected in vitro by gel shift 
analysis (see later section).  
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GUS assay 
  The uidA reporter gene on pMJF2 encodes an E.coli β-glucuronidase 
(GUS). GUS assays were done by the procedure of Feldhaus et al (4). One unit was 
defined as 0.01A415(absorbance at 415 nm) per minute at 37°C. Protein 
concentrations were determined by the method of Lowry et al (7) .  
 
Overexpression and purification of Xis2d  
  pCMK1042, a pET28 vector (Novagen), containing native xis2d (C. 
Keeton, unpublished) was used to overexpress Xis2d. Escherichia coli BL21 (DE3) 
ihfA was used as the host strain. Cells were grown overnight at 37°C in 10ml 
Lysogeny Broth (LB) medium with chloramphenicol (50 µg/ml) and kanamycin (30 
µg/ml). The overnight cultures were used to inoculate 500 ml of LB medium 
containing chloramphenicol (50 µg/ml) and kanamycin (30 µg/ml). The culture was 
incubated with vigorous shaking at 30°C. Cells were grown until O.D.600 was 0.6, 
and isopropyl-D-thiogalactopyranoside (IPTG) was added to a final concentration of 
1 mM. Cells were grown at 25°C for 4 hours with vigorous shaking. Cells were 
sonicated and cell extract was prepared and purified by FPLC heparin column. 
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Xis2d was eluted from heparin column using high salt buffer (50 mM Na-P; pH 7.0, 
2 M NaCl, 1 mM EDTA, 5% glycerol, 1 mM DTT). Active fractions were collected 
and dialyzed in dialysis buffer (5 mM Na-P; pH 7.0, 1 M NaCl, 1 mM EDTA, 40% 
glycerol, 1 mM DTT) and stored at -80°C until use (C. Keeton, unpublished). 
Overexpression and purification of His6-tagged Exc was done as documented by 
Sutanto et al (15).  
 
Overexpression of Xis2c  
  Although Xis2d could be overexpressed and partially purified, attempts 
to purify Xis2c was unsuccessful. Accordingly, for in vitro analysis, we used a 
partially purified preparation of Xis2c for analyzing the binding of Xis2c to mutant 
forms of the traA upstream region. pCMK936, a pET30 vector (Novagen), 
containing native xis2c, (C. Keeton, unpublished) was used to overexpress Xis2c. 
Escherichia coli BL21 (DE3) ihfA was used as the host strain. Cells were grown 
overnight at 37°C in 10 ml Lysogeny Broth (LB) medium with chloramphenicol (50 
µg/ml) and kanamycin (30 µg/ml). The overnight cultures were used to inoculate 
500ml of LB medium containing chloramphenicol (50 µg/ml) and kanamycin (30 
µg/ml). The culture was incubated with vigorous shaking at 37°C. Cells were grown 
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until O.D.600 was 0.3~0.4, and isopropyl-D-thiogalactopyranoside (IPTG) was added 
to a final concentration of 1 mM. Cells were grown at 25°C for overnight with 
vigorous shaking. Cells were harvested by centrifugation at 7,000 rpm for 20 min at 
4°C. The supernatant fluid was discarded, and the cells were stored at –80°C until 
use. The frozen cell pellet was resuspended in 20ml low salt buffer (50 mM Na-P; 
pH7.0, 1 mM EDTA, 50 mM NaCl, 5% glycerol, 1 mM DTT) to which two 
Complete EDTA-free protease inhibitor tablets (Roche Applied Science) and 20 mg 
of lysozyme had been added. The cells were lysed by sonication (10 sec sonication 
and 59.9 sec on ice, 10 times). Cell lysate was separated by centrifugation at 12,000 
rpm for 60 min at 4°C. The crude cell extract was dialyzed overnight in a Slide-A-
Lyze cassette (Thermo Scientific) against dialysis buffer (50 mM Na-P; pH7.0, 1 
mM EDTA, 50 mM NaCl, 5% glycerol, 1 mM DTT, 20% glycerol), and stored at -
80°C until use. Attempts were made to purify Xis2c by heparin agarose column, but 
purification of Xis2c was not successful (C. Keeton, unpulished). 
 
Gel shift assays 
  A 450-bp DNA fragment containing region from –138 to +352 relative  
to traA transcriptional start site were utilized in the gel shift assay experiments. This 
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fragment was used to ensure that all binding sites were included, and the same 
fragment was also used for traA::uidA fusions. DNA fragments were prepared from 
plasmids containing wild-type or mutated PtraA region by restriction enzyme digest 
(SphI and SmaI) followed by gel extraction. DNA fragments were then labeled with 
gamma-[32P] ATP using PCR, and purified. The DNA fragment (approximately 5 ng) 
and either Xis2c crude extract, partially purified Xis2d or Exc were mixed in 10 µl 
binding buffer and be incubated for 15 min at 25°C. The 5X binding buffer contains 
250 mM Tris-HCl (pH 8.0), 5 mM EDTA, 250 mM NaCl, 50% Glycerol, and 3.6 
µg/ml herring sperm DNA. The binding mixture was loaded onto a 6% DNA 
Retardation Gel (Invitrogen), and 0.5X Tris-borate-EDTA buffer (pH 8.0) was used 
as the running buffer. After electrophoresis, the gels were dried and subjected to 
autoradiography. 
 
 
DNaseI footprint assays 
  The upstream region of traA was amplified by PCR using fluorescently 
labeled primers, with either top or bottom strand primers labeled with 6-
carboxyfluorescein (6-FAM). The PCR product contained region from –134 to +78. 
The bp numbers are relative to traA transcriptional start site (+1). Individual 
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footprint reactions were initiated by mixing footprint binding buffer (0.5 mM CaCl2, 
2.5 mM MgCl2, 10 mM Tris-HCl; pH7.5), 6-FAM labeled DNA (10 pmol), and 
water to a final volume of 18 µl. Binding reactions were performed by adding 2µl of 
various amount of Xis2d (60~240 ng) followed by 30 min incubation at 25°C. 2 µl 
of DNaseI (New England Biolabs) at an approximately 1:2000 dilution in 1X 
DNaseI buffer (0.5 mM CaCl2, 2.5 mM MgCl2, 10 mM Tris-HCl; pH7.5) was added 
to each reaction, and incubated for 2 min at 25°C. The digestion reactions were 
stopped by adding 40 µl of 0.5 M EDTA (pH 8.0). DNA segments were then 
immediately purified using QIAGEN PCR cleanup kit. Fragment analysis was done 
at the UIUC DNA Core Facility (Urbana, IL), and the Genemapper software 
(Applied Biosystems) was used for further analysis.  
 
3.3 Results 
Contribution of Xis2c, Xis2d, and Exc to the regulation of CTnDOT transfer 
gene expression 
  Previous work (18) showed that Exc helped to enhance the conjugative 
transfer of pLYL72, a plasmid containing the transfer operon of CTnDOT that are 
necessary for transfer (18). Westen blot analysis showed that deleting part of exc 
abolished the enhanced production of three transfer proteins, TraG, TraN, and TraP  
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(18). It is still not clear whether Exc is required or stimulatory because the Western 
blot analysis was not very sensitive. The effect of in-frame deletion in Xis2c or 
Xis2d on tra gene regulation had not been previously tested. A vector containing 
xis2c and xis2d but no exc resulted in the loss of the increased transfer of pLYL72 
and in the loss of the increased synthesis of key transfer proteins (e.g. TraG) (18). To 
test whether Xis2c, Xis2d, and/or Exc are required to regulate expression of the 
transfer gene operon, we made in-frame deletions in xis2c and xis2d. The 
downstream sequences of xis2c and xis2d were deleted for the exc mutant (Fig. 
3.1A). Both wild-type and deletion mutants were cloned into shuttle vectors then 
tested in strain BT4001ΩQABC (pGW40.5) for their abilities to induce the 
transcription of the traA::uidA fusion when the cells were grown in the presence of 
tetracycline (Fig. 3.1B). A strain containing the tetQ-rteA-rteB, and rteC region 
inserted in the chromosome (18) was used because the deletion clones were under 
the control of the natural excision operon promoter (PE). When the wild-type 
excision operon containing all three genes on a plasmid (pJPARK82) was introduced 
into the strain, the GUS activity of the traA::uidA fusion was increased 150-fold in 
the presence of tetracycline compared to the background level (Fig. 3.1B). When the 
vector contained a deletion in xis2c (pGRW53∆2c), the GUS activity of the cells 
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induced by tetracycline was reduced 58% relative to the wild-type (∆xis2c in Fig. 
3.1B). Thus, the deletion in xis2c reduced but did not abolish tra gene expression. 
The tetracycline-induced activity of traA::uidA was decreased 97% when 
pGRW53∆2d was present (∆xis2d in Fig. 1B), indicating that Xis2d is more 
important than Xis2c for the transcriptional control of the transfer operon. Exc 
deletion resulted in only 16% decreased activity (∆exc, Fig. 3.1B). 
 
Xis2d specifically binds upstream region of traA operon 
  Gel shift assay results showed that both Xis2c and Xis2d were able to 
shift a DNA fragment containing a 450-bp upstream region of TraA and the 
promoter PtraA. No gel shift was seen if an unrelated DNA was used, so the binding 
was specific (J. Lee, unpublished data). Xis2d could be partially purified, but in the 
case of Xis2c we had to use cell extracts due to loss of activity of the protein when it 
is further purified. Thus, we were limited to using Xis2d in footprint experiments to 
try to localize the region(s) where the Xis proteins were binding. Preliminary gel 
shift assay results showed that three different DNA fragments within this fragment (-
89~+251, -164~+15, -89~+15) were bound by Xis2d (J. Lee, unpublished) (Fig. 
3.2A, upper diagram). We used a 212-bp fragment that contained the region of these 
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three different DNA fragments to identify possible binding sites for Xis2d (Fig 3.2A, 
lower diagram). DNaseI footprint assays were performed using fluorescently labeled 
DNA probes containing the 212-bp region from –134 to +78 relative to the traA 
transcriptional start site with the 6-carboxyfluoresceine (6-FAM) label on the 5’ end 
of either the top or bottom strands. The elution profile of Xis2d binding to upstream 
region of traA (Fig. 3.2B) showed a
 
reproducible depression of peak height within 
the region from –81 to –30 relative to the traA transcriptional start site (Fig. 3.2A 
indicated by shaded box, Fig. 3.2C). The base pairs that were protected from the 
DNaseI digest indicated by the arrows (Fig. 3.2C) are bases that are bound by Xis2d 
and thus are presumed to be important. 
 
The effect of PtraA region mutations on binding of Xis2d to DNA 
  To determine if the Xis2d binding sites identified by DNaseI footprint 
assays were important, gel shift assays were done. In the gel shift assays, the 450-bp 
fragments containing either wild-type or site-directed mutations that are indicated by 
the boxed regions in Fig 3.3A were used. The arrows again indicate the bases 
protected by Xis2d (Fig. 3.3A). A distinct shift of the fragment was observed when 
both wild-type Xis2d and wild-type fragment were present. (Fig. 3.3B, lane 2, 
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indicated by a filled arrow). Five different mutations were made by site-directed 
mutagenesis within the 50-bp footprint region of Xis2d, –81 to –30 relative to the 
traA transcriptional start site (Figure 3.3A). Each region subjected for site-directed 
mutagenesis was changed to its complementary sequence to conserve the melting 
temperature characteristics. When regions outside of the Xis2d binding site were 
mutated (-81~-77 and –39~-34, Fig. 3.3A), the DNA fragment was still shifted (Fig. 
3.3B, lanes 4 and 12). Mutations within region that might contain Xis2d binding site 
resulted in loss of binding (Fig. 3.3B, lanes 6, 8, and 10). 
 
The effect of PtraA region mutations on binding of Xis2c to DNA 
  Although mutations within footprinted region had little effect on Xis2d 
binding, it was possible that Xis2c binding might be affected. Gel shift assays were 
done as described for Xis2d above. Due to technical difficulties concerning loss of 
activity observed here and in vitro excision assays (14), we were forced to use Xis2c 
crude cell extracts as our source of Xis2c. Empty vector crude cell extract (same 
vector but no xis2c) was used as a negative control. With wild-type Xis2c and wild-
type PtraA, the shift was observed (Fig. 3.4B, lane 2, indicated by solid arrow). When 
the binding mixture contained only empty vector crude extract, the two bottom 
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bands were present (Fig. 3.4B, indicated by hollow arrows). We checked whether 
mutations within 50-bp footprint region with Xis2d would affect the ability of Xis2c 
to bind to the DNA. All 5 of the mutations prevented the shift of the fragment. This 
result confirmed that
 
Xis2c is a DNA binding protein, and that the region from –81 
to –30 is more important for the observed binding of Xis2c than for Xis2d. 
 
The effect of mutations on in vivo transcriptional activity 
  With the varied results observed for the in vitro binding of Xis2d and 
Xis2c on the 50-bp region, we also wanted to test whether these mutations in the 
region from –81 to –30 had any effects on the in vivo transcriptional activity. The 
same mutations tested in the in vitro gel shift assays were cloned into pMJF2 to 
make traA::uidA fusions. These plasmids were then mobilized into BT4004 where 
an intact CTnERL was used to provide the tetracycline regulated genes (tetQ-rteA-
rteB and rteC) as well as the entire excision operon. Since the expression of excision 
genes is regulated by tetracycline, we again compared the GUS activity with and 
without tetracycline. The results of the five different mutations within the region 
upstream of Xis2d footprint region on the GUS activity of traA::uidA fusions are 
shown in Figure 3.5B. With the wild-type sequence, the GUS activity was increased 
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50-fold in the presence of tetracycline. The GUS activity was reduced nearly to 
background by most of the mutations. Clearly, although the in vitro effects of the 
mutations on Xis2d binding were minimal, the effects of the mutations in vivo were 
significant. Either the in vitro assay did not accurately reflect the effects of 
mutations in this region or Xis2d alone is not sufficient for the effects it has in vivo.   
 
Exc binds the upstream region of traA cooperatively with Xis2d 
  A possible explanation of the lack of effect in vitro of traA upstream 
mutations on Xis2d binding was that in vivo Xis2d is interacting with proteins such 
as Exc. In the gel shift assays, Exc did not shift DNA containing the upstream region 
of of the traA operon
 
(Figure 3.6A), however it is present on the clones which were 
used to determine the in vivo contribution of Xis2c and Xis2d to the transcription of 
traA. Xis2c plus Exc, without Xis2d, had less that 5% the transcriptional induction 
as Xis2d plus Exc. To test the possibility that there is some measurable interaction of 
Exc with Xis2d, we checked whether Exc could bind this region cooperatively with 
Xis2d. The results of the gel shift assays are shown in Figure 3.6. 30 ng of Xis2d 
was used in these assays. With this concentration of Xis2d protein, only the half of 
DNA was shifted (Fig. 3.6B, lane 2, indicated by filled arrow). Addition of 
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increasing amounts of Exc was added which resulted in complete shifting of the 
DNA fragment and the appearance of a super-shift band (Fig. 3.6B, lanes 3 to 8, 
indicated by a hollow arrow). At 64 ng of Exc, all of the fragment is either in the 
first Xis2d band or in the super shift band. From 128 ng of Exc or higher, the 
fragment migrated to the wells (Fig. 3.6A). Thus Exc appears to interact 
cooperatively with Xis2d in some way, possibly by facilitating Xis2d binding to 
DNA (Fig.3.6B). 
 
3.4 Discussion 
  It is unusual that CTnDOT excision genes (xis2c, xis2d, and exc) are 
involved in both excision and transfer. Previously, xis2c and xis2d were designated 
as orf2c and orf2d, but these genes were re-named since they play an important role 
in excision. Xis2c contains a helix-turn-helix (HTH) motif, and both Xis2c and 
Xis2d are small basic proteins. However, they do not have a primary sequence 
homology to known proteins in the databases (14). Exc was shown to have 
topoisomerase function in vitro, although this activity appears not to play a role in 
the activity of Exc in vivo (14). Therefore, my hypothesis was that Xis2c and Xis2d 
are DNA binding proteins that bind the upstream region of the transfer operon as 
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transcriptional activators, and Exc might work cooperatively with these proteins to 
bind to upstream region of traA promoter (PtraA) and enhance the expression of the 
transfer genes. This suggests that the binding of Exc either to Xis2d or to facilitate 
Xis2d binding to DNA is involved rather than some effect of Exc on DNA super-
coiling in the region.  
  Deletion of Xis2c showed 58% reduced activity, but not to the 
background level (Fig. 3.1B). This might be because Xis2d and Exc were still 
present in the absence of Xis2c. Xis2d and Exc bind cooperatively to DNA (Fig. 
3.6B) and this might explain the 42% residual activity. It was not determined 
whether Xis2d alone contributed entire 42% activity in the absence of Xis2c. Xis2d 
deletion resulted in 97% decreased activity (Fig. 3.1B). With Exc deletion, the 
activity was decreased 16%, suggesting that Xis2c and Xis2d together could make 
near wild-type transcription. Without excision genes, the activity was less than 0.1% 
of wild-type activity in the presence and absence of tetracycline.  
  The preliminary gel shift assay used 3 different overlapping DNA 
fragments that all contained a common region between –164 and +251 relative to the 
traA transcriptional start site. Since all fragments were shifted with Xis2c and Xis2d, 
I decided to focus on the common region to footprint of Xis2c, Xis2d, and Exc. 
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Neither Xis2c nor Exc had a specific binding region that could be protected from 
DNaseI digest. I had to use crude cell extract of Xis2c due to technical difficulties to 
purify active Xis2c, and non-specific binding proteins present in the cell extract 
might have interfered specific binding of Xis2c to the traA upstream region. Also, 
Xis2c did not overproduce very well, so the concentration of Xis2c could be too low. 
Partially purified Exc alone did not shift DNA and did not give a footprint within the 
upstream region of traA (Fig. 3.6A), however, Exc interacts cooperatively with 
Xis2d to enhance binding of Xis2d to the upstream region of traA in vitro. This 
supports the hypothesis that Exc interacts with Xis2d in the positive regulation of 
transfer operon.  
  I made 5 different 5~7 bp mutations within the traA upstream. Region 
footprinted by Xis2d to test the effects of these mutations on in vivo activity and in 
vitro DNA binding. The footprint region was 50-bp but there were no repeats or 
inverted repeats observed. Originally, I planned to make 6 different mutations within 
the region footprinted by Xis2d (-81 ~ -30), but I was unsuccessful in constructing 
mutations between –49 and –56. The in vivo GUS assays showed the decreased 
activity to the background level with most of the mutations, and the same mutations 
eliminated Xis2c binding. Mutations within Xis2d footprinted site resulted in loss of 
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Xis2d binding (Fig. 3.3B), while two mutations (-81~-77 and –39~-34) did not 
affect binding of Xis2d to DNA (Fig. 3.3B). 
  In summary, a 50-bp region upstream of traA was footprint by Xis2d and 
this region was also shown to be important for both Xis2c and Xis2d binding by in 
vitro gel shift assays. The footprinted region between –81 and –30 relative to the 
traA transcriptional start site was located immediately upstream of the promoter of 
transfer operon. This supports our hypothesis that Xis2c and Xis2d are DNA binding 
proteins that activate transfer operon expression. Mutagenesis of region upstream of 
traA showed that this region was critical for in vivo activity of the traA::uidA fusion 
and both Xis2c and Xis2d binding in vitro. Previous work showed that Exc is 
required for enhancement of expression of downstream transfer genes in the 
presence of tetracycline (18). In vivo GUS assays with Exc deletion mutant, 
however, showed 16% decreased acvitity. Exc might be involved in translational 
regulation of genes downstream of traA. By performing in vitro gel shift assays with 
Xis2d and Exc, I presented the first evidence that Exc works cooperatively with 
Xis2d to enhance binding to DNA and positively regulates transfer operon  
expression. Exc might also work cooperatively with Xis2c but further purification of 
Xis2c is needed to do test this.  
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Figures and Tables 
 
Figure 3.1 
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Figure 3.1 (continued) 
 
Figure 3.1 Effect of deleting xis2c, xis2d, and exc on the regulation of the 
CTnDOT transfer operon  
(A) Wild-type excision genes, xis2c or xis2d in-frame deletion, and exc deletion 
mutants (pJPARK82, pGRW53∆2c, pGRW53∆2d, and pJPARK83, respectively) 
constructed to test whether Xis2c, Xis2d, and Exc are required to regulate transfer 
gene expression. (B) Plasmid containing either wild-type genes or a deletion mutant 
of xis2c, xis2d, or exc was mobilized into BT4001ΩQABC containing the 
traA::uidA fusion (pGW40.5). The values obtained with wild-type excision operon 
and tetracycline induction were set to 100% and the activity with the each deletion 
mutant is represented as a percentage of the wild-type value. The experiments were 
done in triplicate, and the mean values
 
are shown above. Standard deviations are 
shown as error bars.  
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Figure 3.2 DNaseI footprint analysis of Xis2d to the traA promoter region  
(A) DNA fragments used to determine the location of the Xis2d binding site within 
upstream region of the traA promoter are shown. The numbers above the diagram 
indicate the position relative to the TIS (+1) of the traA gene. The putative tra 
promoter (-33&-7) is indicated with white box. Shaded box includes the region 
protected from DNaseI digest. (B) FAM-labeled DNA fragments were sequenced by 
running parallel didioxy G, C, T, and A reactions. Here, G sequencing ladder is 
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Figure 3.2 (continued) 
 
shown as an example. DNaseI protection sites are underlined. (C) Sequence of 
upstream region of traA is shown. Base pairs that were protected from DNaseI 
digest are indicated by vertical arrows.  
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Figure 3.3 Effects of PtraA mutations on Xis2d binding  
(A) Sequences of 5 different regions of PtraA that were subjected for site-directed 
mutagenesis are shown in boxes. Sequences from –81 to –77 , -71 to –65, –63 from 
to –57, -48 to –44, and –39 to -34 relative to the traA transcriptional start site were 
changed to their complementary sequences. Basepairs that were protected from 
DNaseI digest are indicated by vertical arrows. (B) Gel shift analysis was done to 
test binding of Xis2d to wild-type and mutated upstream regions of PtraA. Reaction 
conditions were as described in the Materials and Methods section. Lanes 1, 3, 5, 7, 
9, and 11contained labeled DNA without any protein. Lanes 2, 4, 6, 8, 10, and 12 
contained labeled DNA and 20 ng of partially purified Xis2d. Extract of cells 
containing empty vector did not shift the DNA (Data not shown). The shifted 
protein-DNA complex is indicated by the arrow. The gel is a representative of three 
independent experiments. 
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Figure 3.4 Effects of PtraA mutations on Xis2c binding  
(A) Sequence of 5 different regions of PtraA that were subjected for site-
directed mutagenesis are shown in boxes. Sequences from –81 to –77 , -71 to 
–65, –63 to –57, -48 to –44, and –39 to -34 relative to the traA transcriptional 
start site were changed to its complementary sequences. (B) Gel shift analysis 
was done to test binding of Xis2c to wild-type and mutated upstream region 
of PtraA. Reaction conditions were as described in the Materials and Methods 
section. Lanes 1, 3, 5, 7, 9, and 11; labeled DNA without any protein; lanes 2, 
4, 6, 8, 10, and 12; binding mix containing 9 µg of Xis2c crude cell extract. 
The other shifted bands indicated by hollow arrows come from an unknown 
component of the crude cell extract preparation. The super-shifted protein-
DNA complex is indicated by the arrow. The gel is a representative of three 
independent experiments. 
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Figure 3.5 Site-directed mutagenesis of the upstream region of PtraA   
(A) Sequence of 5 regions of PtraA that were subjected for site-directed mutagenesis 
are shown in boxes. sequences from –81 to –77 , -71 to –65, –63 to –57, -48 to –44, 
and –39 to -34 relative to the traA transcriptional start site were changed to its 
complementary sequences. (B) In vivo GUS assay results are shown. In each case, 
wild-type PtraA or the PtraA mutations were fused to the E.coli uidA gene creating 
translational fusions, and then mobilized into Bacteroides strain BT4004. In each 
panel, the values obtained with wild-type PtraA induced by tetracycline; +Tc) were 
set to 100% and the activity of the each PtraA mutant is represented as a percentage 
of the wild-type PtraA value. Without PtraA, the GUS activity was less than 1U/mg 
protein. The experiments were done in triplicate, and the mean values are shown. 
Standard deviations are shown as error bars. 
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Figure 3.6 Exc binds upstream region of traA cooperatively with Xis2d  
(A)
 
Gel shift analysis was done to test binding and cooperativity of Exc to upstream 
region of PtraA. Gel shift assay shown here is for Exc alone. (B) Gel shift assay was 
done in the presence of both Xis2d and Exc. Increasing concentrations of Exc 
(0~512 ng) were added to 30 ng of Xis2d and tested for ability to shift the 450-bp  
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Figure 3.6 (continued) 
 
upstream PtraA region. Filled arrow indicates the DNA shift by Xis2d. The super-
shifted protein-DNA complex is indicated by hollow arrow. The gel is a 
representative of three independent experiments. 
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Table 3.1 Bacterial Strains and Plasmids 
 
Strain or plasmid   Relavant Phenotype    Description and Reference 
E.coli 
DH5αMCR         RecA                Gibco BRL 
HB101(RP1)        RecAStrr                    HB101 containing IncPα plasmid RP1 (88) 
BL21(DE3)         Camr                         Cells enable high-level expression of  
                                       heterologous proteins in E.coli (Stratagene) 
 
B. thetaiotaomicron 5482A 
BT4001             Rifr                           Spontaneous rifampin-resistant mutant 
BT4001ΩQABC      Tcr                  BT4001 with site-specific insertion of  
                                        tetQ, rteA, rteB, and rteC into the  
                                        chromosome via NBU1 mini-insertion vector 
BT4004             RifrTcr                       B. thetaiotaomicron 4001 that contains  
                                        wild-type CTnERL 
 
Plasmids 
pMJF2              Apr(Emr)              A cloning vector to create a uidA fusion, also 
                                         an E.coli-Bacteroides shuttle vector  
pC-COW            AprCmr(Cmr)           pC-COW is pTC-COW digested by PvuII 
                                         and relegated 
pGW40.5            AprCmr(Cmr)          Contains fusion PtraA::uidA cut out of pMJF2 
                                         by PvuII and cloned into NruI site of pC-COW,  
                                         along with wild-type traA promoter (5) 
pCR-Blunt            Knr                  A 3.5-kb cloing vector for PCR product 
                                         (Invitrogen) 
pET27b              Knr                  A plasmid for the overexpression of proteins 
                                          in E.coli (Novagen) 
pET30               Knr                  A plasmid for the overexpression of proteins 
in E.coli (Novagen) 
pJPARK82            Apr(Emr)              7.6-kb SphI-SstI fragment from pKSO1(18) 
                                          containing the excision gene operon cloned 
                                          into the SphI-SstI site of pAFD1  
                                          (this study) 
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Table 3.1 (continued) 
pJPARK83            Apr(Emr)              2.1-kb SphI-SstI fragment from pGW41(18) 
                                          containing xis2c, xis2d, but exc cloned 
                                          into the SphI-SstI site of pAFD1  
                                          (this study) 
pJPARK85             Knr                           0.5-kb SphI-SmaI fragment containing 
                                          -138 to +352 relative to the traA transcriptional 
                                          start site cloned into pCR-Blunt (This study) 
pJPARK90             Knr                  0.5-kb SphI-SmaI fragment containing 5-bp  
                                           mutation cloned into pCR-Blunt 
                                           5-bp (-81 to –78 relative to the traA 
                                           transcriptional start site) was changed to 
                                           complementary sequence by site-directed 
                                           mutagenesis (This study) 
pJPARK95             Knr                  0.5-kb SphI-SmaI fragment containing 7-bp  
                                           mutation cloned into pCR-Blunt 
                                           5-bp (-63 to –57 relative to the traA 
                                           transcriptional start site) was changed to 
                                           complementary sequence by site-directed 
                                           mutagenesis (This study) 
      pJPARK100            Apr(Emr)              0.5-kb SphI-SmaI fragment from pJPARK85 
                                                 cloned into the SphI-SmaI site of pMJF2 
                                                 (This study) 
pJPARK104            Apr(Emr)              0.5-kb SphI-SmaI fragment from pJPARK90 
                                                 cloned into the SphI-SmaI site of pMJF2 
                                                 (This study) 
pJPARK108            Apr(Emr)              0.5-kb SphI-SmaI fragment from pJPARK95 
                                                 cloned into the SphI-SmaI site of pMJF2 
                                                 (This study) 
pJPARK119            Knr                  0.5-kb SphI-SmaI fragment containing 7-bp  
                                           mutation cloned into pCR-Blunt 
                                           5-bp (-71 to –65 relative to the traA 
                                           transcriptional start site) was changed to 
                                           complementary sequence by site-directed 
                                           mutagenesis (This study) 
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Table 3.1 (continued) 
pJPARK120            Knr                  0.5-kb SphI-SmaI fragment containing 7-bp  
                                           mutation cloned into pCR-Blunt 
                                           5-bp (-48 to –44 relative to the traA 
                                           transcriptional start site) was changed to 
                                           complementary sequence by site-directed 
                                           mutagenesis (This study) 
pJPARK121            Knr                  0.5-kb SphI-SmaI fragment containing 6-bp  
                                           mutation cloned into pCR-Blunt 
                                           5-bp (-39 to –34 relative to the traA 
                                           transcriptional start site) was changed to 
                                           complementary sequence by site-directed 
                                           mutagenesis (This study) 
pJPARK122            Apr(Emr)              0.5-kb SphI-SmaI fragment from pJPARK119 
                                                 cloned into the SphI-SmaI site of pMJF2 
                                           (This study) 
pJPARK123            Apr(Emr)              0.5-kb SphI-SmaI fragment from pJPARK120 
                                                 cloned into the SphI-SmaI site of pMJF2 
                                           (This study) 
pJPARK124            Apr(Emr)              0.5-kb SphI-SmaI fragment from pJPARK121 
                                                 cloned into the SphI-SmaI site of pMJF2 
                                           (This study) 
pGRW53∆2c            Apr(Emr)             3.5-kb fragment containing in-frame deletion 
                                           of xis2c cloned into pAFD1 (This study) 
pGRW53∆2d            Apr(Emr)             3.5-kb fragment containing in-frame deletion 
                                           of xis2d cloned into pAFD1 (This study) 
pCMK936              Knr                           365 bp NdeI-HindIII fragment containing 
                                           native xis2c cloned into the NdeI-HindIII 
                                           site of pET30a (C. Keetoon, unpublished) 
pCMK1042             Knr                 458 bp NdeI-XhoI fragment containing native  
                                           xis2d cloned into the NdeI-XhoI site of  
                                           pET27b (C. Keeton, unpublished) 
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Chapter 4 
  CONCLUDING REMARKS AND FUTURE STUDIES 
 
  Conjugative transposons (CTn) play an important role in spreading 
antibiotic resistance genes among bacteria by horizontal gene transfer (1, 3, 4, 8, 13). 
CTnDOT is a CTn found in Bacteroides species (11, 12), and responsible for 
spreading antibiotic resistance genes among Bacteroides species (10, 12, 16). 
Previous work in our laboratory has shown that regulation of CTnDOT is a very 
complex process, and that regulation of CTnDOT excision and transfer is triggered 
by tetracycline (2, 7, 15).  
  At first, I studied a positive regulator of CTnDOT excision, RteC. Little 
was known about this regulatory protein when I started to work on this project. I 
found that RteC is a winged-helix type DNA binding protein that binds two inverted 
repeat half sites within the upstream region of the excision gene operon, and 
activates the expression of the excision genes. Because of the lack of primary 
sequence homology of RteC to known protein databases, I looked for the structural 
homologs using the Robetta protein structure prediction server. Using the three-
dimensional structural model prediction, I was able to find homologs of this unique 
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protein, RteC. It is also interesting to note that a couple of human transcriptional 
factors, E2F-4 and DP2, are the most likely structural homologs of RteC.  
  Once excision of CTnDOT occurs, the next step is transfer from donor to 
recipient by conjugation. For my second project, I focused on the positive regulators 
of CTnDOT transfer. In CTnDOT, three excision proteins (Xis2c, Xis2d, and Exc) 
are required for both excision and transfer (2, 6, 14, 15). My work confirmed that 
both Xis2c and Xis2d are DNA binding proteins that bind to the upstream region of 
the transfer operon to activate the transfer genes. Exc did not bind to DNA by itself, 
but it appears to work cooperatively with Xis2d to enhance Xis2d binding to DNA.  
  I have completed the initial characterization of the positive regulators of 
CTnDOT excision and transfer. My hypothesis is that RteC forms a tetramer to bind 
two inverted repeat half-sites within a region upstream of the promoter of the 
excision operon, PE, and that Xis2c and Xis2d interact with each other to bind to the 
upstream region of the CTnDOT transfer operon to activate transfer gene expression. 
The next step is to take a more in-depth look at the protein complexes these proteins 
form.  
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4.1 Further characterization of RteC 
  I used His6-tagged RteC for in vitro gel shift assays to increase the ease 
of purification and detection. Yet, there were other non-specific binding proteins 
present after cobalt column purification, and this resulted in a non-specific DNA-
protein complex in gel shift assays. Therefore, I used partially purified empty vector 
as a negative control. To get past this hurdle, further purification of RteC will need 
to be done. Affinity purification using the His6-tag will be done followed by either 
heparin column purification or size exclusion chromatography. Size exclusion 
chromatography followed by native gel analysis and Western blotting will also be 
done to confirm RteC oligomerization result shown in Chapter 2. Once pure RteC 
has been obtained, the next step will be the crystallization of RteC and RteC-DNA. 
This experiment will confirm that RteC has a winged helix motif and that the two 
inverted repeat half-sites are contacted by the putative helix 3.  
  My work showed that RteC is a DNA binding protein that binds two 
inverted repeat half-sites within the upstream region of the excision operon. Future 
work with DNaseI footprint assays will be done with further purified RteC to 
confirm both the in vivo GUS assays and the in vitro gel shift assay results. Further, 
the upstream region of xis2c can be amplified by PCR using fluorescently labeled 
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primers, with either the top or bottom strand primers labeled with 6-
carboxyfluorescein (6-FAM). Different concentrations of RteC will be added to 
binding mixtures containing 6-FAM labeled DNA probe followed by DNaseI digest. 
Footprint assay samples will be immediately cleaned up by Qiagen PCR clean up kit, 
and subjected to the fragment analysis. Lastly, results will be analyzed using 
GeneMapper software to interpret the footprint data.  
 
4.2 Mutagenesis of Xis2c and Xis2d  
  Xis2c and Xis2d play an important role in both excision and transfer of 
CTnDOT. Yet, it was not determined in detail how these proteins mediate excision 
and activation of transfer gene expression. Accordingly, Xis2c and Xis2d mutants 
that are defective in excision could be selected and tested for their abilities to 
activate transfer gene expression. Due to the lack of primary sequence homology of 
known databases proteins, random mutagenesis will be done to identify important 
amino acid residues within Xis2c and Xis2d for excision. Hydroxylamine, a 
chemical that targets G:C pairing and deaminates the cytosine to uracil, will be used 
to generate random Xis2c and Xis2d mutants.  
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  To isolate mutants defective for excision, a blue/white colony selection 
in E.coli will be done. This screen has already been developed in the Gardner 
laboratory. There are five components required for excision of CTnDOT: Xis2c, 
Xis2d, IntDOT, BHFa, and the attL/attR sites (14). In an E.coli in vivo system, two 
plasmids will be used to select excision mutants. An indicator plasmid that contains
 
intDOT and lacZ cloned between the attL/attR sites. During excision, Xis2c and 
Xis2d bind attL/attR sites (14). This plasmid also contains λattP site, which allows 
it to integrate into the E.coli chromosome via site-specific recombination with the 
host encoded attB site. The second plasmid will contain xis2c and xis2d and be 
provided in trans. If Xis2c and Xis2d mutants are able to bind at attL/attR site, they 
will disrupt the expression of
 
lacZ resulting in a white colony. Therefore, blue 
colonies will be selected as excision mutants.  
  Once excision mutants are selected, these mutants will be cloned into 
E.coli-Bacteroides shuttle vector, pAFD1, and mobilized into the Bacteroides strain 
BT4001ΩQABC containing pGW40.5. BT4001ΩQABC contains the central 
regulatory region (tetQ-rteA-rteB, and rteC) on the chromosome, and pGW40.5 
contains a traA::uidA fusion. If excision mutants are functional in activation of
 
transfer gene expression, they will bind the upstream region of traA provided by 
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pGW40.5, and show high GUS activity in the presence of tetracycline. To confirm 
the in vivo GUS assay results, in vitro gel shift assays will be done with excision 
mutants to test whether these mutants are still capable of binding the transfer region.  
 
4.3 Determination of protein-protein interactions between Xis2c, Xis2d  
and Exc 
  Xis2c and Xis2d are small basic DNA-binding proteins that are located 
right next to each other. Therefore, it is possible that these proteins form oligomers 
that bind to the transfer region. To test for protein-protein interactions, co-expression 
of Xis2c and Xis2d, followed by size exclusion chromatography will be done. In this 
case, one of the proteins will be labeled with 35S-methionine for detection. Then the 
labeled protein will be separated on a two dimensional SDS-PAGE gel and subjected 
to autoradiography for quantification and identification.  
  Another way to detect protein-protein interaction is protein complex 
immunoprecipitation (Co-IP). Co-IP works by selecting an antibody that targets a 
known protein in the hypothesized protein complex (5, 9), in our case, antibodies 
will be made for Xis2c, Xis2d and Exc. By targeting a known protein with an 
antibody it may possible to pull an entire protein complex out of solution and 
thereby isolate the other proteins that form the complex. It will be interesting to see 
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whether all three antibodies identify the same complex. This experiment could give 
us some insights into the protein composition and stoichiometry of the active 
complex. 
 
4.4 DNaseI footprint assays of PtraA with Xis2c 
  I showed that Xis2c is a DNA binding protein that binds the upstream 
region of PtraA. To identify the region Xis2c binds and to confirm in vitro gel shift 
assay results in Chapter 3, DNaseI footprint assays of PtraA with Xis2c will be done. 
To do this, further purification of Xis2c will be done. Purification of Xis2c using 
heparin column resulted in loss of activity. Therefore, cell extract containing 
overexpressed Xis2c will be purified using size exclusion chromatography followed 
by ion-exchange chromatography. Once pure Xis2c is obtained, crystallization of 
protein and protein-DNA will also be done to determine the structure and regions 
that contact DNA.  
  
4.5 Determine tetracycline regulation of mobilization genes  
  In CTnDOT, mobilization genes are located upstream region of transfer 
genes. By performing qualitative RT-PCR, I and another student in our laboratory (J. 
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Waters) found that mob genes are regulated by tetracycline. Quantitative RT-PCR 
will be done to confirm this result. I showed in Chapter 3 that a 50-bp region 
upstream of traA is important for Xis2c and Xis2d binding. Since the promoter 
regions of both mob and tra genes are adjacent to each other, it is possible that the 
two excision proteins, Xis2c and Xis2d, that were shown to bind upstream of the 
traA promoter also bind the mob promoter and enhance the expression of both 
mobilization and transfer genes in the presence of tetracycline. Therefore, I checked 
whether upstream region of mob genes contain the similar region to 50-bp upstream 
of traA that were found to be important for Xis2c and Xis2d. Although no homology 
was found, Gel shift assays will be done to check whether Xis2c and Xis2d could 
bind PmobA region. If these proteins bind region upstream of mobA, then DNaseI 
footprint assays will be done to identify their binding sites and these will be 
compared to sites obtained of Xis2d.  
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